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 DOWN SYNDROME – INSIGHTS FROM MURINE MODELS 
  
Down syndrome (DS) is a genetic pathology caused by triplication of chromosome 21 
(Hsa21) and is characterized by a number of physical and mental abnormalities, with 
intellectual disability (ID) as the most serious health problem. Complexity of  DS arises from 
the substantial genetic basis of syndrome, the dysfunction of multiple systems and the high 
phenotypic variability of its clinical manifestations among affected individuals (Antonarakis 
and Epstein, 2006). Virtually all people living with DS have a triplication of at least one 
segment of Hsa21 being responsible for inappropriate development and resulting in structural 
and functional anomalies that persist throughout the entire lifespan. Beside the disruption of 
development, trisomic gene expression affects also the properties of differentiated adult cells, 
compromising further their already altered functions.  
Sequencing of Hsa21 and identification of its mouse ortholog genes have led to 
generation of  transgenic mice that have enabled remarkable advances in better understanding 
of the DS nature. The mouse is the organism of choice in modern biomedical research as it 
allows a vast degree of genetic alteration, high reproducibility of experiments due to the 
1breeding simplicity and use of intrusive studies. Respect to human genome, orthologs in 
mouse differ minimally in the structures of conserved genes (Gardiner and Davisson, 2000), 
although differences in regulation of gene expression may be expected (Gharib and 
Robinson-Rechavi, 2011). Importantly, developmental programs and basic mechanisms of 
mature functions are conserved across mammals. In line with this is the occurrence of DS like 
phenotype in mice trisomic for Hsa21 orthologs (Das and Reeves, 2011). 
The advantage of DS mouse models for translational research is not only a successful 
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recapitulation of disease aspects, but also a predictive ability, i.e. certain phenotypic 
abnormalities for the first time observed in trisomic mice have been confirmed later in DS 
patients (Belichenko et al., 2004). Moreover, systematic investigation of these models 
enables a more precise definition of genotype-phenotype interaction, better understanding of 
altered molecular pathways and identification of potential therapeutic targets, and finally 
design of preclinical studies with treatments likely to be tested in clinical trials. 
 
1.1. The human trisomy 21 
DS is a complex clinical entity caused by trisomy of Hsa21 (T21) and characterized by 
numerous features affecting multiple systems, with cognitive impairment as the most 
prominent and deleterious symptom. With the prevalence of 1 in 850-1000 infants  (Shin et 
al., 2009) DS represents the leading cause of ID of genetic origin and an important public 
health issue due to inability of affected individuals to live an independent life. DS was 
described for the first time in 1866 by John Langdon Down, but the link of its numerous 
features with T21 was revealed only later in 1959 by the cytological profiling study 
performed by Jerome Lejeune (Megarbane et al., 2009). In the majority of cases DS is caused 
by the full T21 (95%), but the occurrence of two other genetic variations including 
translocation T21 (4%) and mosaic T21 (1%) also gives rise to DS phenotype (Parker et al., 
2010). The full T21 is due to a meiotic nondisjunction of Hsa21 that is related to an advanced 
age of mother in about 75% of DS cases, while in remaining 25% it has paternal origin 
(Turleau and Vekemans, 2010). This nondisjunction seems to be associated with errors in 
recombination and an age-dependent loss of meiotic chromosome cohesion (Hassold and 
Hunt, 2001, Hodges and Wallace, 2005), but why these recombinant mistakes take place and 
how their consequential burden of DS could be avoided it is still far away from being 
understood.      
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The presence of an additional copy of Hsa21 implicates a quantitative rather than a 
qualitative nature for DS. However, genes situated in Hsa21 account for a less than 2% of 
total genomic material (Gardiner and Davisson, 2000), leading to the intriguing question of 
how can such a relatively modest quantitative genomic alteration give rise to such serious 
pathological consequences. According to the ‘‘gene dosage effect hypothesis’’, particular 
phenotypic traits associated with T21 are direct consequences of the imbalance of  individual 
genes located on the triplicate chromosome (Pritchard and Kola, 1999, Antonarakis et al., 
2001, Antonarakis et al., 2004). In agreement with this hypothesis is the identification of 
several “dosage-sensitive” regions, including genes and noncoding conserved elements, 
across the length of Hsa21, that have been shown to be sufficient for induction of typical 
features of DS individuals (Korbel et al., 2009, Lyle et al., 2009). On the contrary, the 
“amplified developmental instability hypothesis” postulates that triplication of a relative 
small number of genes disrupts global gene expression and regulation of intracellular 
signaling pathways, leading to deleterious effects on development and function (Hall, 1965, 
Shapiro, 1983, Pritchard and Kola, 1999, Moldrich et al., 2007). The main strength of this 
hypothesis is in the interpretation of DS as a “genomic disorder”, which suggests overlapping 
underlying mechanisms between DS and other trisomies. A synthesis of these opposite 
approaches proposes that some dosage sensitive genes, whose triplication per se would have 
only modest effects, may account for the numerous DS phenotypes only in combination with 
other triplicate genes (Olson et al., 2004, Roper and Reeves, 2006).  
Similar to other conditions caused by chromosome imbalance, DS afflicts structure 
and function of multiple systems, producing detrimental effects on physical and mental 
health. Additionally, the clinical manifestations of DS change across the lifespan, 
contributing further to the complexity of syndrome (Antonarakis and Epstein, 2006). The first 
line of health problems are congenital malformations that include craniofacial and skeletal 
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dysmorphic features with more cosmetic than functional effects (Frostad et al., 1971, Fischer-
Brandies, 1988), and significant cardiovascular (Ferencz et al., 1989) and gastrointestinal 
(Levy, 1991) anomalies that, if not treated properly, could lead to serious morbidity. Presence 
of cancer phenotype is controversial, as at the birth there seems to exist an increased risk for 
myieloproliferative disorders, while in the adulthood prevalence of many malignant tumors is 
decreased (Wechsler et al., 2002). The second line of symptoms develops progressively 
during life and, beside growth retardation, obesity, thyroid dysfunction and male sterility 
(Antonarakis and Epstein, 2006), it refers mostly to central nervous system (CNS) 
dysfunctions. CNS symptomatology of DS starts with central hypotonia at birth and 
continues with delayed cognitive development in infancy and childhood, leading to mild to 
moderate mental retardation that aggravates in adulthood, with an additional loss of cognitive 
abilities due to precoocious development of Alzheimer disease (AD). Generally, the lifetime 
of DS individuals is shorter with respect to the normal population and its duration is strongly 
influenced by the constellation of clinical signs that vary enormously in prevalence and 
severity across DS population.  
Despite the numerous health problems mentioned above, life quality of people living 
with DS has been improved significantly due to enhanced medical and social care, which also 
resulted in an increased life expectancy from 12 years in 1940s to the current 60 years and 
over (Glasson et al., 2002, Roizen and Patterson, 2003, Bittles and Glasson, 2004, Bittles et 
al., 2007). However, CNS abnormalities are still orphan of an effective therapy, with ID 
being the most significant obstacle to an independent life for DS individuals. The availability 
of animal models in the field of DS basic research has started to reveal underlying 
mechanisms of T21 that contribute to the etiology of CNS dysfunction and cognitive 
impairment, providing the basis for designing of clinical trials aiming at the amelioration of 
mental abilities (Reeves and Garner, 2007, Wetmore and Garner, 2010, Rissman and Mobley, 
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2011, Haydar and Reeves, 2012)  
 
1.2. Modeling Down syndrome in mice 
The basis for modeling DS in mice is a conserved synteny between the long arm of Hsa21 
and mouse chromosomes 16 (Mmu16), 17 (Mmu17) and 10 (Mmu10) (Pletcher et al., 2001). 
The long arm of Hsa21 is approximately 33.7 Mb in length and contains ~ 430 protein-
coding genes, of which ~175 have a homolog in the mouse genome. The distal end of 
Mmu16 carries the largest homolog region containing 37Mb. This region spans from Rbm11 
to Znf295 and is composed of ~115 orthologous genes with a subset of them, such as Ncam2, 
App, Grik, Sod, Synj1, Olig1, Olig2, Dyrk1a, Girk2, Bace2, being involved in brain 
development and functioning (Haydar and Reeves, 2012). The two remaining homolog 
regions are identified on Mmu17 and Mmu10 and are much smaller, containing 1.1 Mb and 
2.3 Mb  and consisting of 19 and 41 orthologous genes, respectively (Das and Reeves, 2011).  
The spontaneous Robertsonian translocations of Mmu16 naturally occurs in mice 
(Gropp et al., 1975) and this trisomy for Mmu16 (Ts16) has been considered the first model 
of DS. However, Ts16 model has a limited experimental use due to its very low postnatal 
viability, probably caused by trisomy of portions of Mmu16 that show sinteny with genes 
encoded by Hsa3, 8, 12, 6 and 22, which are not involved in etiology of DS (Moore and 
Roper, 2007). Genetic engineering of different segments of Hsa21-orthologues genes resulted 
in the availability of a comprehensive set of transgenic strains carrying those genes that show 
synteny with Hsa21 (Sérégaza et al., 2006). Importantly, these transgenic strains outlive Ts16 
mice and may be studied at any developmental stage and across the entire lifespan. 
The most important group of transgenic DS models encompasses mouse lines with 
triplication of various portions of the distal end of Mmu16. The most widely used and 
characterized model is Ts65Dn, which carries segmental trisomy in a form of small 
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chromosome produced by a Robertsonian translocation of Mmu16 to Mmu17. Trisomy in 
this model expands from Mrpl39 to Znf295 (Kahlem et al., 2004) and results in a dosage 
imbalance for ~104 genes conserved on Mmu16. Introduction of this model has been 
fundamental as it demonstrated for the first time that trisomy for syntenic genes of Hsa21 
gives raise to DS-related outcomes in mice (Reeves et al., 1995). A detailed phenotypic 
characterization of Ts65Dn mice revealed a number of abnormalities in cognitive 
performance and brain morphology similar to those observed in people with DS. These 
findings have encouraged the use of Ts65Dn mouse as a standard to compare the incidence 
and severity of trisomic phenotypes reported in mouse models that came afterward (Holtzman 
et al., 1996, Baxter et al., 2000, Richtsmeier et al., 2000, Cooper et al., 2001, Rueda et al., 
2005, Lorenzi and Reeves, 2006, Moore, 2006, Roper and Reeves, 2006). 
Additionally developed partial trisomies carry smaller set of genes compared to 
Ts65Dn mice. In the case of the Ts1Cje model, the trisomic segment spans from Sod1 to 
Znf295 and counts for ~81  orthologous (Sago et al., 1998), while the Ts1Rhr model has a 
triplication for even a smaller region composed of ~33 genes expanding from Cbr1 to Orf9 
(Olson et al., 2004). Ts1Cje and Ts1Rhr mice also show cognitive impairments, but the 
severity of their deficits is generally attenuated in comparison with Ts65Dn (Sago et al., 
1998, Olson et al., 2007, Belichenko et al., 2009a). More complex models can be created 
when a third copy of a gene or chromosomal segment is subtracted from existing segmental 
trisomies by crossing them to a strain that carries a null allele/s for the gene/segment of 
interest thereby decreasing dosage of targeted gene/segment to euploid levels in the context 
of remaining trisomy (Salehi et al., 2006, Sussan et al., 2008). For instance, both 
Ms1Cje/Ts65Dn and Ms1Rhr/Ts65Dn were produced by breeding the corresponding 
monosomy of Ts1Cje and Ts1Rhr trisomies to the Ts65Dn mouse (Sago et al., 2000, Olson et 
al., 2004). These models have been developed in an attempt to understand the contribution of 
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specific orthologous genes to particular features of DS. However, the phenotypic analysis of 
these models revealed that the putative DS critical region (DSCR), believed to contain all 
essential genes responsible for the typical characteristics of DS, is not critically involved in 
the learning and memory deficit (Olson et al., 2007). These findings challenged the concept 
of specific dosage-sensitive genes as a primary cause of an abnormal phenotype of DS and 
rather supported the hypothesis that the over-expression of a large number of triplicated 
genes generally disrupts genomic homeostasis, leading to impaired regulation of 
developmental processes (Shapiro, 1997). 
The models that are trisomic for the two remaining syntenic regions of Hsa21 mapped 
on Mmu17 and Mmu10 have been used to provide additional insights into the genetic basis of 
DS. The Ts1Yah mouse carries three copies of 12 genes, spanning from U2af1 to Abcg1, of 
the Mmu17 syntenic to the sub-telomeric region of Hsa21 (Pereira et al., 2009). This model 
has been created in order to understand how the telomeric region of Hsa21 contributes to DS 
phenotype. The effects of trisomy on learning and memory in Ts1Yah model are 
contradictory as some aspects of cognitive performance are impaired, while other are even 
improved with respect to euploid controls, emphasizing the concept that a complex 
interaction between genes underlies behavioral alterations in trisomic mice (Pereira et al., 
2009). Interestingly, the Ts2Yey model, that contains triplication for 41 genes of the Mmu10 
region which is homologue to the Hsa21 telomeric end, does not show any cognitive 
impairment (Yu et al., 2010). Recently, a ‘triple trisomy’ model, the Ts1Yey;Ts2Yey;Ts3Yey 
mouse, has been developed. The Ts1Yey;Ts2Yey;Ts3Yey mouse is the first model with a 
dosage imbalance for all the Hsa21 orthologous found in the mouse genome and it carries in 
triplicate the syntenic segments from all three mouse chromosomes, Mmu16, Mmu17 and 
Mmu10 (Yu et al., 2010). Nevertheless, the revealed brain phenotype of this model is very 
close to the Ts65Dn  justifying the use of the Ts65Dn mouse as the referent murine model for 
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DS (Yu et al., 2010). Beside DS models based on synteny between human and mouse 
genome, a transchromosomic model, Tc1, has been also introduced. Tc1 mice have a 
transferred copy of Hsa21, but the human chromosome is lost in a subset of cells from all 
tissues (O'Doherty et al., 2005). The mosaicism for Hsa21 reported in this model could 
account for the mild cognitive deficits display by Tc1 mice (O'Doherty et al., 2005).   
Given that the cognitive performance is the most compromised function in DS, the 
behavioral phenotypes of DS models have been thoroughly assessed to establish their 
relevance for the human condition. Particularly, impairments of spatial and recognition 
learning and memory have been studied in depth by use of a battery of behavioral tests that 
have helped to identify the hippocampus as the brain region specifically affected by trisomy 
in mice (Das and Reeves, 2011). In addition to behavioral evaluations, hippocampal 
morphological and electrophysiological correlates of cognitive deficits have been studied in 
DS models revealing a clear relationship between the number of trisomic genes that are 
orthologous to Hsa21 and the level of expression of functional and structural abnormalities.  
 
1.3. Central nervous system dysfunction in Down syndrome – comparison 
between affected humans and Ts65Dn mouse model 
1.3.1. Cognitive and behavioral impairments 
Humans  
Difficulties in intellectual functioning are the most striking feature of DS. The major obstacle 
to an independent life in DS patients are limitations in cognitive performance that are 
additionally complicated by functional difficulties coming from various areas, such as 
linguistic, social, motor, and sensory. However, similarly to other genetic disorders 
associated with ID, different domains of intellectual processing in DS are not affected to the 
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same level by T21, leading to a complex cognitive profile characterized by specific 
weaknesses and strengths (Fidler et al., 2006).  
Cognitive impairments in DS could be classified into those that are a product of 
disrupted neural development resulting in retardation of learning and memory from birth, and 
those that occur in adulthood as a consequence of accelerated neurodegenerative processes 
(Contestabile et al., 2010). DS individuals during the course of childhood and adolescence 
develop mild to severe ID that, when expressed with the Intelligence Quotient (IQ), falls into 
the range from 30 to 70 (Vicari et al., 2000, Vicari et al., 2004, Vicari et al., 2005). Cognitive 
development of DS infants begins relatively typically and the first delays are observed at the 
age of two years which may be associated with the myelination lag at this developmental 
stage (Koo et al., 1992). One of the key features of the overall slowdown in maturation of 
learning abilities for children with DS are difficulties in the maintenance of acquired skills 
and a persistent use of counterproductive strategies for novel problem solving tasks (Wishart, 
1993).  
Learning deficits in DS children refer to both short-term and long-term memory 
(Carlesimo et al., 1997, Vicari et al., 2000, Brown et al., 2003, Vicari et al., 2005). When 
assessed with tasks requiring low processing levels, visuospatial components of short-term 
and working memory tend to be speared in contrast to verbal processing, which instead 
demonstrates significant deficits respect to age-matched controls (Vicari et al., 1995, Jarrold 
et al., 1999, Vicari et al., 2006). As the task becomes more demanding, certain impairments 
emerge also in the visuospatial skills, and those reported for verbal processing worsen 
(Lanfranchi et al., 2004, Visu-Petra et al., 2007). Strengths and weaknesses are also present in 
domain of long-term memories. Explicit memory is significantly compromised in DS 
children due to poor information encoding, impaired retrieval abilities and attention deficits  
(Carlesimo et al., 1997, Brown et al., 2003, Krinsky-McHale et al., 2008), whereas learning 
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abilities for tasks requiring implicit memory processing seem to be preserved (Vicari et al., 
2000). This is in agreement with a different mechanism underlying this two types of memory 
formation, as implicit memory is a more automatic process based on low levels of attention, 
while explicit memory requires a high degree of attention to carry on intentional learning and 
develop successful retrieval strategies.  
Impairment of long-term memory in DS has been associated with hippocampal and 
prefrontal lobe dysfunctions. Namely, deficit in spatial long-term memory reported in pre-
school DS children assessed by delayed recall of place learning task (Pennington et al., 2003) 
pointed to altered hippocampal function, whereas impairment of non-verbal reasoning ability 
and attention has indicated a specific executive control defect due to abnormal prefrontal 
functioning, supporting the concept that ID in DS is differentially affected by the degree of 
required control (Rowe et al., 2006). A high prevalence of behavioral disinhibition, illustrated 
by hyperactivity, aggression, stubbornness, disobedience, impulsivity and already mentioned 
attention deficits (Cuskelly and Dadds, 1992, Dykens et al., 2002), is also indicative of 
prefrontal dysfunctions in DS. Recognition memory, another type of explicit memory 
partially dependent on hippocampus (Yonelinas et al., 2005) and frontal lobe (Neufang et al., 
2006) integrity, is also affected in DS. DS children perform normally in the task of matching 
photographs of simultaneously presented faces, but perform significantly worse in the more 
demanding task of matching faces to non-present people (Wishart and Pitcairn, 2000). Thus, 
similarly to described working memory deficits, the level of task difficulty determines the 
quality of recognition memory performance, indicating that in DS cognitive deficits may be 
generally more pronounced in challenging situations.  
In addition to developmental ID, DS patients may undergo additional cognitive 
decline with aging and develop precocious AD (Nieuwenhuis-Mark, 2009). Although at the 
neuropathological level virtually all subjects with DS develop typical hallmarks of AD during 
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adulthood (Ball and Nuttall, 1980, Hof et al., 1995, Folin et al., 2003, Nadel, 2003, Lott and 
Head, 2005), only a portion of patients demonstrate clinical signs of dementia (Devenny et 
al., 1996, Devenny et al., 2005). Clinical progression of AD in DS has some similarities with 
dementia onset in the general population, with confusion, forgetfulness, impairment of recent 
memories and a relative preservation of distant memories at early stages of disease (Deb et 
al., 2007). On the other hand, the signs of frontal lobe dysfunction, such as indifference, 
apathy, depression, socially-deficient communication and impaired adaptive functioning 
(Zigman et al., 1996, Lott and Head, 2001, Ball et al., 2006), may be expressed during initial 
phase of AD in some cases of DS (Deb et al., 2007, Ball et al., 2008), while among the 
general population these clinical manifestation typically occur only in a late phase of AD.  
As discussed above, frontal lobe abnormalities and defective executive functions have 
been also reported in young DS subjects (Rowe et al., 2006), emphasizing the diagnostic 
difficulties in detecting cognitive decline caused by dementia in the context of ID 
(Nieuwenhuis-Mark, 2009). Moreover, in DS the risk of developing some forms of mental 
disease increases over time (Dykens et al., 2002), representing an additional confounding 
factor in the correct diagnosis of the cognitive deficit. Depression is the most common 
psychiatric problem among young adults affected by DS (Myers and Pueschel, 1991, 
Collacott et al., 1992) and its progression may lead to additional decline in adaptive behavior 
and cognitive performance during mid and late adulthood (Burt et al., 1992).  
 
Ts65Dn  
Similarly to human DS subjects, disruption of neural development processes leads to early 
cognitive impairments also in Ts65Dn mice (Bianchi et al., 2010b), with a further worsening 
occurring in adulthood due to neurodegenerative processes (Hyde and Crnic, 2001, Faizi et 
al., 2011).  
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Short-term working memory has been assessed by spontaneous alternation tasks, 
revealing a reduced performance in Ts65Dn mice (Fernandez et al., 2007, Belichenko et al., 
2009a) and resembling short-term memory deficits observed in DS individuals (Lanfranchi et 
al., 2004, Visu-Petra et al., 2007). Furthermore, Ts65Dn mice, as well as persons with DS, 
are characterized by a functional dissociation between implicit and explicit long-term 
memory. Namely, Ts65Dn mice perform similarly to wild type (WT) mice in implicit 
memory tasks, as indicated by normal acquisition and maintenance of skills in the rotarod 
performance test (Hyde and Crnic, 2001, Fernandez et al., 2007).  
On the other hand, Ts65Dn mice demonstrate selective impairments in explicit 
learning and memory tasks. Two prototypical domains of explicit memory that can be 
delineated in rodents through a variety of behavioral tasks are spatial and recognition learning 
and memory. These experimental paradigms depend on the functional integrity of the medial 
temporal lobe, composed of the hippocampus and the parahippocampal region, the same 
areas associated with deficits in declarative memory displayed by patients with DS (Nelson et 
al., 2005). A particular vulnerability of the trisomic hippocampus is well illustrated by the 
outcomes of two different forms of fear conditioning. In an acoustic fear conditioning, a 
behavioral test based on the amygdale (Anagnostaras et al., 1999), Ts65Dn mice do not show 
any significant defect (Salehi et al., 2009, Faizi et al., 2011), while there is a clear evidence of 
impaired performance in a context fear conditioning (Costa et al., 2008, Salehi et al., 2009, 
Bianchi et al., 2010b, Faizi et al., 2011), a paradigm mainly dependent on the hippocampus 
(Kim and Fanselow, 1992).  
The most frequently used test to assess spatial long-term learning and memory in 
Ts65Dn mice is the Morris water maze (MWM). This paradigm evaluates visuospatial 
integration, as mice are trained to find a platform hidden in a tank filled with an opaque 
water, using a complex spatial mapping strategy based on extra- and intra-maze cues  
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(Morris, 1984, Redish and Touretzky, 1998). It has been repeatedly shown that Ts65Dn mice 
perform similarly to euploid mice in a cued task that does not involve visuospatial integration 
because the hidden platform is marked with visible cues such as a flag (Escorihuela et al., 
1998, Sago et al., 2000, Bimonte-Nelson et al., 2003, Rueda et al., 2008). This indicates that 
motivation is not affected in Ts65Dn mice which have sufficient motor and visual skills to 
reach a visible platform. However, in the hidden-platform task Ts65Dn mice display 
significant navigational impairments and a general inability to create successful strategies to 
find and remember the position of the platform (Escorihuela et al., 1995, Reeves et al., 1995, 
Demas et al., 1996, Holtzman et al., 1996). It is important to note that deterioration in the 
performance of Ts65Dn mice in MWM may be partially due to a stressful nature of the test as 
a certain degree of aversiveness is an integral part of MWM (Stasko and Costa, 2004). This 
indicates that challenging situations are more prone to reveal deficits not evident in stress-
free circumstances. This is also supported by the recent finding that Ts65Dn mice show 
identical outcomes as WT mice in place preference and place avoidance learning tasks when 
tested in the home cage environment, which can be considered a stress-free condition (Faizi 
et al., 2011). However, recognition memory evaluated by non aversive object recognition 
tests is also impaired in Ts65Dn mice, illustrating the persistence of some cognitive deficits 
even in low stress circumstances. Ts65Dn mice exhibit significant deficits in the simple 
version of the novel object recognition task (a simple protocol involving a pair of identical 
objects during the familiarization phase), but a complete inability to distinguish novel and 
familiar objects in the complex version of the test (a more challenging protocol involving a 
pair of different objects during the familiarization phase) (Fernandez et al., 2007). 
Importantly, the profile of this impairment is in accordance with previously described 
neuropsychological studies in human DS, reporting more pronounced difficulties in 
intellectual processing in DS patients with increasing task demands (Lanfranchi et al., 2004, 
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Visu-Petra et al., 2007).  
The majority of the above mentioned behavioral tests refers to young adult Ts65Dn 
mice at the age of  3-4 months, but for some tasks longer follow up studies have been 
performed, allowing to uncover an additional amount of cognitive performance decline with 
age (Hyde and Crnic, 2001, Faizi et al., 2011). This is reminiscent of the cognitive 
deterioration due to an early onset of AD among DS individuals. It has been proposed that 
hyperactivity, frequently observed in Ts65Dn mice (Davisson et al., 1993, Reeves et al., 
1995, Coussons-Read and Crnic, 1996, Stewart et al., 2007)  may be an early sign of AD in 
this model. Namely, it has been shown that prefrontal cortex lesions leads to hyperactivity in 
rodents (Kolb, 1974, Takakusaki, 2008), and this type of disinhibited behavior in Ts65Dn 
mice could be driven by an altered prefrontal information processing, as it has been shown to 
be the case in the human DS (Rowe et al., 2006).  
 
1.3.2. Motor and sensory abnormalities 
Humans 
Together with a poor cognitive performance, various motor and sensory deficits are 
associated with DS. Acquisition of motor milestones generally follows the same sequences 
found in typically developing children, but is characterized by significant delays that tend to 
be more pronounced for the latest milestones (Palisano et al., 2001, Vicari et al., 2006). Two 
typical characteristics of DS that significantly influence motor performance are low muscle 
tone and lack of control of muscle stiffness (Davis and Sinning, 1987, Vicari et al., 2006). 
Impairments are evident in all motor domains, as illustrated by a poor performance in tasks 
assessing fine and gross motor skills and motor planning (Jobling, 2001, Mon-Williams et al., 
2001). However, performance in some specific skills, like running speed, agility and visual-
motor control, reaches the level of age-matched controls (Jobling, 2001, Mon-Williams et al., 
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2001) indicating that some qualities of motor function are preserved in DS.  
The development and function of auditory and visual pathways are also affected by 
T21 (Folsom et al., 1983, Diaz and Zuron, 1995). Hearing loss occurs in approximately two 
thirds of DS children and is one of their most common sensory disabilities (Roizen et al., 
1993). During infancy there is a high incidence of conductive hearing loss due to congenital 
malformation of the ear anatomy and repetitive ear infections, while progressive 
sensorineural loss is frequently found from middle childhood to adult life, as demonstrated by 
difficulties to evoke potentials by auditory stimulus in the brainstem (Jiang et al., 1990, Chen 
and Fang, 2005).  
Although less frequent then auditory defects, visual system impairments are also an 
integral component of DS symptomatology. Visual acuity (VA), the ability to see fine 
details of objects, and contrast sensitivity, the ability to discriminate between different 
brightness levels, are reduced in infants and children with DS when compared with their 
normally developing peers (Courage et al., 1994, Woodhouse et al., 1996). Ophthalmic 
anomalies, such as refractive errors (Woodhouse et al., 1997), accommodative inaccuracy 
(Cregg et al., 2001), strabismus (Haugen and Hovding, 2001), and nystagmus (Wagner et al., 
1990) are typical of DS patients, but cannot entirely account for their reduced vision, because 
children without such anomalies still show poor VA and contrast sensitivity (John et al., 
2004). Abnormalities in cortical visual evoked potentials (VEPs) in DS patient rather point to 
a functional deficit of central visual pathways (Ellingson, 1986). The basis of this 
dysfunctional visual processing may be structural dendritic abnormalities characterized by 
progressive loss of dendritic branching and total length in the visual cortex, during the period 
from the first postnatal months to the two years of age (Becker et al., 1986). In adulthood, 
some DS patients show AD-like visual deficits (Rocco et al., 1997), as impaired color 
discrimination and stereoacuity, the ability to detect differences in distance, indicating that 
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both congenital abnormalities and age-related neuropathology within the visual pathways 
could contribute to sight defects. 
Overall, the importance of motor and sensory deficits in DS is not only in the primary 
loss of their functions, but also in the capability to negatively influence the intellectual 
functions already compromised by trisomy.  
 
Ts65Dn  
Assessment of motor and sensory function in Ts65Dn mice has demonstrated that acquisition 
of developmental milestones in trisomic pups recapitulates the abnormal aqusition of motor 
and sensory skills of DS infants (Holtzman et al., 1996, Palisano et al., 2001, Vicari et al., 
2006). Motor function has been evaluated in detail and it has been reported that young adult 
Ts65Dn mice display an altered motor performance in several paradigms including grip 
force, running and swimming speed and motor coordination in the rotarod test (Costa et al., 
1999). The motor coordination deficit and its relevance for gait has been additionally 
investigated by motorized treadmills and the CatWalk automatic gait analysis system, 
revealing abnormalities in walking patterns and dynamics (Hampton et al., 2004, Faizi et al., 
2011). The main deficits reported in Ts65Ds mice correspond to gait abnormalities observed 
also among DS children (Shumway-Cook and Woollacott, 1985, Parker et al., 1986, Galli et 
al., 2008).   
While well studied in DS subjects, sensory deficits have been reported only recently 
in trisomic mice. Ts65Dn mice have elevated thresholds for auditory-evoked brainstem 
responses (ABR) compared to WT controls (Han et al., 2009). This finding faithfully 
recapitulates human deficits as an earlier clinical study found that ABR thresholds of DS 
infants are higher than those found in typically developing children (Werner et al., 1996). 
Similarly to the conductive nature of hearing loss among young DS population (Buchanan, 
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1990, Hassmann et al., 1998), auditory deficits in Ts65Dn mice have been correlated with a 
high prevalence of otitis media, thought to be provoked by altered craniofacial dimensions 
and middle ear anatomy (Hill et al., 2007) and depressed immune function (Han et al., 2009). 
However, while hearing loss aggravates with age in patients with DS due to additional 
sensorineural complications (Chen and Fang, 2005), ABR time-course experiments show a 
time-stable hearing loss in Ts65Dn mice (Han et al., 2009).  
Loss of vision has been also recently reported for the first time in Ts65Dn mice. 
Similarly to persons with DS (John et al., 2004), recordings of VEPs revealed that Ts65Dn 
mice have lower spatial resolution, the electrophysiological correlate of VA, and higher 
contrast threshold, the electrophysiological inverse correlate of contrast sensitivity, than WT 
mice (Scott-McKean et al., 2010). Electroretinography assessments showed no significant 
deficits in retinal physiology in Ts65Dn mice in comparison with WT control mice (Scott-
McKean et al., 2010), supporting the assumption based on clinical studies that a dysfunction 
of  central components of visual processing may be involved in the visual deficits associated 
with DS (John et al., 2004).  
 
1.3.3. Neuroanatomical correlates of neurophysiological impairments  
Humans  
Morphological alterations characteristic of the DS brain arise from a disruption of neural 
development leading to abnormal anatomy and connectivity of CNS, evident from the earliest 
evolutionary stages, and from a progressive atrophy believed to result from AD-like 
neurodegeneration, occurring during adulthood and superimposing on the existing neural  
changes. 
Brain volume is smaller in DS subjects compared to age-matched healthy controls, 
even after normalizing for body size that is generally reduced in DS (Yoshimura et al., 1990, 
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Raz et al., 1995). Macroscopic analysis of postmortem brain tissue and ultrasonographical 
data have shown that the reduction of the overall volume of DS brain emerges during prenatal 
development (Winter et al., 2000, Guihard-Costa et al., 2006) and progresses further during 
the gestational period (Schmidt-Sidor et al., 1990, Golden and Hyman, 1994, Engidawork 
and Lubec, 2003). Singular brain areas are also modified by trisomy as illustrated by small 
cerebellum, frontal and temporal lobes, reduced number and depth of the cerebral sulci and a 
narrow superior temporal gyrus (Coyle et al., 1986, Wisniewski, 1990, Becker et al., 1991). 
Magnetic resonance imaging (MRI) studies have confirmed these regional brain 
abnormalities, emphasizing a disproportional reduction of cerebellar and hippocampal 
volumes in young DS subjects (Raz et al., 1995, Pearlson et al., 1998, Aylward et al., 1999, 
Pinter et al., 2001).  
In agreement with the reduced volumes, lesser amount of neurons has been calculated 
in the hippocampus, the parahippocampal gyrus, cerebellum and neocortex of DS fetuses 
(Baxter et al., 2000, Guidi et al., 2008, Larsen et al., 2008) and in the cortex of DS children 
(Wisniewski, 1990), indicating that morphological alterations observed among young DS 
individuals may arise from decreased output of newborn neurons during development. Direct 
evidence that T21 disrupts neurogenesis at early developmental stages has come from the 
study showing that cell proliferation is impaired in the dentate gyrus (DG) and ventricular 
germinal matrix in the brains of DS fetuses at 17-21 weeks of gestation (Contestabile et al., 
2007). Further analyses revealed that the G2 phase of neuronal cell cycle is prolonged in DS, 
probably accounting for slower proliferative rate during neurogenesis (Contestabile et al., 
2007) and fewer numbers of differentiated neurons in the DS developing brain (Guidi et al., 
2008). An increased apoptotic rate has been also reported in the hippocampus of DS fetuses 
contributing to the overall lack of neural cells in this brain structure (Guidi et al., 2008). 
Moreover, T21 significantly modifies hippocampal cell phenotypes producing more cells 
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with a glial phenotype and less cells expressing neuronal markers (Guidi et al., 2008). 
Significant neurogenesis impairments were also found in the cerebellum of fetuses with DS, 
while the rate of apoptotic cell death was similar to controls (Guidi et al., 2011), pointing to 
different mechanisms underlying reduced cell numbers in the hippocampus and cerebellum.  
Numerous brain structures of DS individuals brain undergo further atrophic changes 
with age. Similarly to patients with sporadic AD, old DS subjects are characterized by 
extensive cerebral atrophy, extracellular deposition of the amyloid β peptide (Aβ) in the brain 
parenchyma and blood vessel walls (amyloid angiopathy) and accumulation of intraneuronal 
neurofibrillary tangles (NFT) composed of a hyperphosphorilated form of tau protein (Mann, 
1988, Jellinger and Bancher, 1998). Neuropathological changes in sporadic AD typically 
occur over 65 years of age and follow a specific sequence, as in the preclinical stadium they 
affect transentorhinal and entorhinal cortex, while in more advanced stages of the disease 
they extend to the hippocampus and neocortical regions (Braak and Braak, 1997). On the 
contrary, almost all DS patients demonstrate AD pathology by the age of 30, with the earliest 
pathological markers occurring in the medial temporal lobe and spreading to the prefrontal 
cortex, basal ganglia, thalamus, hypothalamus and midbrain (Wisniewski et al., 1985). The 
pathological alterations of these regions are believed to underlie the age-dependent cognitive 
decline in DS patients, as indicated by a positive correlation between the number of plaques 
or tangles and the degree of dementia severity (Blessed et al., 1968, Ropper and Williams, 
1980, Terry and Davies, 1980, Wilcock and Esiri, 1982, Ulrich, 1985, Wisniewski et al., 
1985). Importantly, MRI studies have revealed that in some particularly vulnerable brain 
regions, such as the hippocampus and the amygdala, atrophic changes precede the clinical 
onset of dementia, emphasizing that evaluation of regional atrophy may help to identify 
people with DS in the prodromal stages of AD (Krasuski et al., 2002).  
An important factor for the overall co-morbidity and early onset of AD in DS subjects 
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is an increased Aβ burden due to an additional copy of the amyloid precursor protein (APP) 
gene mapped on Hsa21 (Rumble et al., 1989). Aβ is the major constituent of extracellular 
insoluble aggregates that are considered to be key morphological markers for AD. Increasing 
evidence indicates that overproduction of Aβ, besides its role in the formation of fibrillar 
aggregates, interferes with physiological mechanisms underlying learning and memory, 
triggering an early onset of dementia in DS (Conti and Cattaneo, 2005, Gasparini and 
Dityatev, 2008). It has been demonstrated that Aβ oligomers, small soluble clusters of Aβ, 
alter synaptic plasticity of excitatory synapses in rodents (Lambert et al., 1998, Wang et al., 
2002, Townsend et al., 2006, Shankar et al., 2008, Li et al., 2009), and clinical data illustrate 
that Aβ oligomers in AD patients are even better correlated with clinical symptoms then Aβ 
plaques (Mc Donald et al., 2010).  
Deterioration of cognitive performance in old DS subjects has been also related to 
degeneration of basal forebrain cholinergic neurons (BFCNs). Deficits in the cholinergic 
system are very similar to those occurring in AD (Mufson et al., 2008, Schliebs and Arendt, 
2011) and loss of BFCN and decreased activity of choline acetyltransferase (ChAT) have 
been observed in both DS and AD (Whitehouse et al., 1982, Yates et al., 1983, Casanova et 
al., 1985, Mann, 1988, Mufson et al., 1993). The function of basal forebrain cholinergic 
system is apparently normal in DS fetuses and infants (Kish et al., 1989, Lubec et al., 2001) 
and the number of neurons and ChAT activity start to decrease later during adolescence and 
adulthood (Yates et al., 1983, Casanova et al., 1985, Godridge et al., 1987, Mann, 1988, 
Mufson et al., 1993, Schneider et al., 1997), further supporting the view that degenerative 
processes occur in DS subjects during aging (Contestabile et al., 2010). 
The aberrant developmental and degenerative mechanisms in DS act together at the 
cellular level to alter the morphological properties of dendrites. The receptive function of 
dendrites relies on the integrity of dendritic spines that are critically involved in brain 
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connectivity and plasticity (Sorra and Harris, 2000, Kasai et al., 2003, Newpher and Ehlers, 
2009). Abnormalities in density and morphology of dendritic spines and reduced dendritic 
branching have been associated not only with DS but also with other forms of ID 
(Huttenlocher, 1990, Kaufmann and Moser, 2000, Dierssen and Ramakers, 2006). Spine 
density and length and branching of dendrites are reduced in hippocampus and cortex of DS 
brain (Suetsugu and Mehraein, 1980, Takashima et al., 1981, Becker et al., 1986, Takashima 
et al., 1989, Ferrer and Gullotta, 1990, Schulz and Scholz, 1992, Takashima et al., 1994). 
Interestingly, in the fetal period and during the earliest postnatal months, normal, or even 
increased, dendritic branching has been observed in the visual and prefrontal cortex of DS 
brain (Takashima et al., 1981, Becker et al., 1986, Vuksic et al., 2002) indicating that DS 
neurons reach the same structural complexity typical of age-matched controls. However, the 
period of early postnatal maturation is characterized by a greater dendritic retraction of DS 
neurons respect to typically developing infants, resulting in the gradual appearance of 
dendritic abnormalities during the first months of age (Takashima et al., 1981). Dendritic 
abnormalities emerging in childhood progress with age, as illustrated by additional reductions 
of spine density and dentridic length and branching in aged adults with DS (Takashima et al., 
1989). This age-dependent deterioration of dendritic phenotype is consistent with the early 
onset of AD among DS patients as dendritic pathology accompanies also initial stages of AD 
and correlates significantly with the progressive decline of mental faculties (Baloyannis, 
2009).   
 
Ts65Dn  
Differentially from human DS, the overall size of postnatal Ts65Dn brain is not altered 
(Reeves et al., 1995). On the contrary, anatomical changes have been detected in specific 
brain regions, such as cerebellum and hippocampus, indicating that cognitive deficits 
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displayed by this model are based on selective vulnerability of specific neural circuits rather 
than on gross anatomical changes.  
A reduction of cerebellar volume has been found in trisomic pups (Roper and Reeves, 
2006) indicating that, similarly to human DS, the neuroanatomical modifications of Ts65Dn 
mice emerge at early stage of neural development. Morphological alterations of cerebellum 
have been analyzed in depth, reveling that both the molecular layer and the internal granular 
layer of Ts65Dn mice are thinner respect to WT controls due to decreased densities of 
Purkinje neurons and granular cells (Baxter et al., 2000). These findings have a predictive 
value as similar deficits in cerebellum structure were found afterwards also among people 
with DS (Baxter et al., 2000). Interestingly, despite the structural deficit, Ts65Dn mice 
perform as well as control mice on tasks designed to evaluate typical cerebellar functions, 
such as balance and motor coordination (Baxter et al., 2000, Hyde and Crnic, 2001). Since, 
however, increasing findings suggest an involvement of the cerebellum in various learning 
and memory paradigms (Rondi-Reig and Burguiere, 2005, Burguiere et al., 2010), the 
contribution of described cerebellar developmental deficits to some aspects of cognitive 
dysfunction in DS should not be ruled out. 
Structural abnormalities have been observed also in the hippocampus and they are in 
agreement with a poor performance in hippocampus-dependent cognitive tasks displayed by 
Ts65Dn mice. The overall volume of hippocampus does not seem altered in Ts65Dn mice up 
to 7 months of age (Insausti et al., 1998, Lorenzi and Reeves, 2006, Olson et al., 2007), but 
significant structural alterations are evident in the hippocampal subfields from early life  
(Lorenzi and Reeves, 2006, Costa et al., 2008, Salehi et al., 2009, Bianchi et al., 2010b, Faizi 
et al., 2011). In the DG of Ts65Dn mice the number of granule cells and the volume of hilus 
and the granule cell layer are slightly reduced already at postnatal day 6 (P6) indicating that 
this early developmental hypocellularity may contribute to the specific behavioral 
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impairments reported in young trisomic mice (Lorenzi and Reeves, 2006).  
Similarly to human DS, there is a growing body of evidence suggesting that the major 
determinant of morphological brain alteration may be a defective neurogenesis process 
during early developmental stages. Substantial delays in prenatal growth of the Ts65Dn 
cerebral cortex and hippocampus have been linked to longer cell cycle duration and reduced 
neurogenesis from the ventricular zone (Chakrabarti et al., 2007), while the deficit in 
cerebellar formation has been correlated to defective response of granule cell precursors to 
the signaling pathway mediated by the sonic hedgehog (SHH) growth factor (Roper et al., 
2006). Emerging evidence indicates that adult neurogenesis in both the DG and the 
subventricular zone is also altered in trisomic mice and it has been postulated that this deficit 
could be involved in ID, as therapies aimed at rescuing postnatal neurogenesis have been able 
to ameliorate some aspects of cognitive performance (Clark et al., 2006, Bianchi et al., 2010a, 
Bianchi et al., 2010b, Chakrabarti et al., 2011). 
Additional morphological alterations associated with aging occur also in Ts65Dn 
mice. Elevated levels of APP (Seo and Isacson, 2005) and Aβ (Netzer et al., 2010) have been 
reported in the cortex and hippocampus of Ts65Dn mice, but this model does not develop 
typical pathological hallmarks of AD (Reeves et al., 1995, Kurt et al., 2004). The occurrence 
of age-related cognitive decline in the absence of plaques and tangles and the recent 
demonstration that lowering Aβ levels rescues learning and memory in Ts65Dn mice (Netzer 
et al., 2010) support the hypothesis that soluble Aβ forms may be crucially  involved in the 
pathophysiology of AD. Similarly to human pathology, BFCN are also affected by trisomy in 
Ts65Dn mice. It has been reported that an elevated expression of APP in Ts65Dn mice 
provokes an enlargement of early endosomes employed in axonal trafficking and an 
impairment of retrograde transport of nerve growth factor (NGF) from the hippocampus to 
the basal forebrain, leading to degeneration of BFCNs (Cataldo et al., 2003, Salehi et al., 
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2006, Chang and Gold, 2008). NGF is a neurotrophic factor that enhances the survival, 
differentiation and function of specific neurons of the peripheral and central nervous systems, 
including BFCNs (Sofroniew et al., 2001). A critical involvement of APP in the loss of 
BFCNs is illustrated by the reversion of the degenerative phenotype after infusion of NGF 
(Cooper et al., 2001). The degeneration of BFCN in Ts65Dn mice occurs from 6-10 up to 20 
months of age (Holtzman et al., 1996, Granholm et al., 2000, Hunter et al., 2004, Lockrow et 
al., 2009) and may account for age-related impairments in learning and memory (Hyde and 
Crnic, 2001, Hunter et al., 2003). Given that BFCNs provide strong modulatory inputs to the 
hippocampus, the cholinergic deafferentation may in turn underlie age-related volume 
reductions of hippocampal subfields (Kurt et al., 2004). However, differentially from 
observations in humans, the activity of ChAT appears to be increased in the cortex and 
hippocampus of 10 months old Ts65Dn mice and remains stabile even in older mice (Cooper 
et al., 2001, Seo and Isacson, 2005, Contestabile et al., 2006, Contestabile et al., 2008, Chen 
et al., 2009) indicating a possible activation of some compensatory synaptic mechanisms that 
may attenuate the impact of cholinergic loss on cognitive decline in this model.  
Similarly to human DS, significantly reduced spine density and dendritic complexity 
of the cortical pyramidal neurons and the hippocampal pyramidal and granular neurons have 
been observed in adult Ts65Dn mice compared to control littermates (Dierssen et al., 2003, 
Belichenko et al., 2004, Belichenko et al., 2007). Electron microscopy has revealed that these 
dendritic abnormalities are accompanied by a size increment of presynaptic boutons, 
postsynaptic spines and average length of synaptic cleft (Belichenko et al., 2004). Dendritic 
alterations are already present at P21 indicating that, similarly to human DS, trisomy alters 
spine dynamic in Ts65Dn mice from early stages of development. Importantly, it has been 
revealed that various types of synapses are differentially affected by the trisomic condition. In 
the dentate granule cells of the hippocampus, there is a shift of inhibitory synaptic 
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connections away from the dendritic shafts and onto the dendritic necks, which would be 
expected to facilitate inhibitory synaptic transmission given the significantly reduced volume 
of the spine neck compared to the shaft (Belichenko et al., 2004). Moreover, inhibitory 
synapses have greater apposition lengths in Ts65Dn mice while excitatory synapses are 
unaltered, indicating a shift towards excessive inhibition in these mice (Belichenko et al., 
2009b). The altered spine morphology and shift towards excessive inhibition characterizing 
DS may directly affect information processing by suppressing not only excitatory synaptic 
transmission, but also plasticity related signaling cascades that frequently rely on 
depolarization-mediated calcium influx into the postsynaptic structural domains (Cramer and 
Galdzicki, 2012). 
 
1.3.4. Disruption of neurotransmitter systems and neurotrophic factors 
Humans  
In addition to the above discussed alterations in the cholinergic system, the glutamatergic, 
serotonergic, noradrenergic and γ-aminobutyric acid (GABA)-ergic systems are also 
profoundly disrupted in DS individuals. Reduced levels of serotonin (5-HT), GABA and 
dopamine (DA) have been reported in the frontal cortex of trisomic fetuses in comparison to 
euploid fetuses (Whittle et al., 2007). The imbalance in these neurotransmitter systems that 
emerges from the prenatal period may be involved in the disruption of numerous aspects of 
DS brain development. It has been shown that 5-HT plays an important role in neurogenesis, 
neuronal differentiation, dendritic development, axon myelination and synaptogenesis 
(Whitaker-Azmitia, 2001). Additionally, there is a defect in a dynamic of 5-HT receptors 
illustrated by an earlier peak of serotonin 5-HT1A receptors in developing DS brains (Bar-
Peled et al., 1991). Reduction of GABA levels is also expected to impact the formation of DS 
brain as during development GABA acts as an epigenetic factor that controls cell 
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proliferation, neuroblast migration and dendritic maturation (Represa and Ben-Ari, 2005). 
The expression of three GABAA receptor subunits is also altered in the early prenatal life in 
DS, with up-regulation of subunit α2 and down-regulation of α5 and β3 subunits 
(Bhattacharyya et al., 2009). In the brain of adults with DS, 5-TH is below the levels of age-
matched control group and is accompanied with a reduction in the levels of glutamate, 
aspartate and noradrenaline (NA) (Godridge et al., 1987, Risser et al., 1997). Reduced levels 
of 5-HT and NA in aged DS individuals are probable due to a degenerative loss of neurons 
from the dorsal raphe nucleus and locus coeruleus (Mann et al., 1985, Coyle et al., 1986), 
which send the serotonergic and noradrenergic inputs to the forebrain, respectively.  
Disruption of neural development and accelerated neurodegenerative mechanisms in 
DS may be also affected by alterations of neurotrophin systems. Neurotrophins represent an 
important family of small proteins secreted in the vertebrates nervous system, that includes 
NGF, brain derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3) and neurotrophin-4 
(NT-4) (Meakin and Shooter, 1992, Huang and Reichardt, 2001). During development, 
neurotrophins regulate cell survival and differentiation, axon growth, dendrite pruning, the 
innervation pattering and the expression of neurotransmitters and ion channels necessary for 
normal neural functions. In the mature nervous system, neurotrophins continue to modulate 
neural survival and also take part in the control of synaptic function and plasticity (Huang 
and Reichardt, 2001, Sofroniew et al., 2001). Neurotrophins exert their action throughout two 
different classes of receptors. While all trophic factors bind to the p75 neurotrophin receptor, 
each of them also binds to specific members of the surface tyrosine receptor kinases (Trks): 
NGF to TrkA, BDNF and NT-4 to TrkB, and NT-3 to TrkC and to TrkA (Meakin and 
Shooter, 1992, Meakin et al., 1992, Chao and Hempstead, 1995). So far, clinical studies 
concerning DS have been focused on NGF and BDNF expression. Reduced serum levels of 
NGF have been found in children with DS (Calamandrei et al., 2000). Similarly, in the DS 
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fetal brain samples it has been found a lower expression  of BDNF and TrkB isoforms 
(Toiber et al., 2010). On the other hand, opposite results were reported from adult individuals 
with DS, as illustrated by a significant increase of their BDNF blood plasma level with 
respect to age-matched controls (Dogliotti et al., 2010). New studies are necessary to better 
understand this apparent discrepancy in BDNF levels (lower expression in fetuses and higher 
expression in adults) between developing and aging DS brain.  
 
Ts65Dn  
Neurotransmitter levels and receptor expressions have been also investigated in Ts65Dn 
mice, indicating an alteration of multiple systems. However, some data show discrepancies 
with respect to human findings. For example, there are no changes of 5-HT levels in the 
hippocampus of Ts65Dn mice (Bianchi et al., 2010b) as well as no alterations in the number 
of serotonergic neurons of the dorsal and medial nuclei (Megias et al., 1997). On the 
contrary, reduction has been found in the expression of 5-HT1A receptors in hippocampal 
neurospheres and the hippocampus of newborn Ts65Dn mice (Bianchi et al., 2010b). As this 
receptors have been implicated in the regulation of neurogenesis (Malberg et al., 2000), their 
lower expression may contribute to the impairments of neural proliferation found in trisomic 
mice. This is supported by the rescue of early postnatal neurogenesis in Ts65Dn mice after 
treatment with the selective serotonin reuptake inhibitor (SSRI) fluoxetine that increases the 
expression of the 5-HT1A receptors up to normal levels (Bianchi et al., 2010b). Analyses of 
inhibitory and excitatory neurotransmitter systems in Ts65Dn mice have been particularly 
focused on the alterations in receptor subunit composition. The hippocampal region-specific 
distributions of immunoreactivity for α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
receptor (AMPA) receptor subunits GluR1 and GluR2, GABAA receptor subunits α1 and 
β2/3, and GABAB receptor subunits R1 or R2 were investigated at 3 and 8 months of age, 
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revealing significant alterations in the expression of AMPA GluR2, GABAA β2/3 and 
GABAB R1 subunits respect to euploid animals (Belichenko et al., 2009b). Namely, in young 
Ts65Dn mice an overall decrease for AMPA GluR2 and GABAA β2/3 subunits was reported, 
while in older Ts65Dn mice it was found a reduction of AMPA GluR2, GABAB R1 and 
GABAA β2/3. The most interesting result is probably the age-dependent diminution in the 
expression of GluR2 and GABAB receptor subunit R1, in contrast with an increase in the 
expression of GABAA receptor subunit β2/3. The composition of  N-methyl-D-aspartate 
receptor (NMDA) receptors appears normal in neonatal and young adult brains of Ts65Dn 
mice (Pollonini et al., 2008, Fernandez et al., 2009), but there is a reduced brain expression of 
the subunits NR2A and NR2B at 10 months of age (Vink et al., 2009). Although the 
physiological consequences of these alterations in the expression of AMPA, GABA and 
NMDA receptors are still unclear, a contribution to the additional cognitive decline found in 
older Ts65Dn mice may be expected. The noradrenergic system is also affected in Ts65Dn 
mice. Although the number of β-adrenergic receptors in the cerebral cortex and hippocampus 
of Ts65Dn mice is similar to that of euploid mice, their function, as assessed through analysis 
of 3',5'-cyclic AMP (cAMP) formation, is impaired and there is a reduced basal and 
stimulated production of cAMP (Dierssen et al., 1997). 
Expression of neurotrophic factors is also defective in Ts65Dn mice. Reduction of 
BDNF levels in Ts65Dn mice have been observed in the hippocampus at 15 days and 3 
months of age (Bianchi et al., 2010b, Fukuda et al., 2010) and in the frontal cortex at 6 
months of age (Bimonte-Nelson et al., 2003). Importantly, normalization of BDNF 
expression induced by treatment with fluoxetine was able to restore survival of newborn 
cells, differentiation, and granule cell number in Ts65Dn mice (Bianchi et al., 2010b). Recent 
evidence has established an important link between chromosome 21-derived microRNA 
mirna21 and above mentioned deficits in expression of 5-HT1A receptor and BDNF in 
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trisomic brains. It has been demonstrated that mirna21 are overexpressed in the DS brain and, 
consequentially, a downregulation in the expression of the transcriptor factor methyl-CpG-
binding protein (MeCP2) does occur (Kuhn et al., 2010). Numerous mutations in the MeCP2 
gene have been associated with the neurodevelopmental disorder Rett syndrome (RS) (Amir 
et al., 1999), indicating a possible involvement of this gene also in DS brain pathology. 
MeCP2 activates the expression of numerous genes, including 5-HT1A receptor and BDNF 
(Chahrour et al., 2008), suggesting the possibility that reduced levels of these two proteins in 
Ts65Dn brain may be caused by silencing of MeCP2 gene. Given that fluoxetine 
administration increases MeCP2 expression in the DG (Cassel et al., 2006), it is possible to 
hypothesize that epigenetic modifications might also contribute to the restoration of a normal 
expression of 5-HT1A receptor and BDNF in Ts65Dn mice after treatment with fluoxetine 
(Bianchi et al., 2010b).  
The impact of abnormal retrograde transport of NGF on progressive age-dependent 
degeneration of BFCNs in adult Ts65Dn mice have been discussed in the previous sections. 
However, it seems that there is a deficit in the hippocampal NGF expression also in the early 
postnatal period (Bianchi et al., 2010b), indicating that abnormal NGF dynamics should be 
also investigated in the context of DS neurodevelopmental pathology. Finally, increased 
levels of NT-3 have been found in total brain extracts of neonate Ts65Dn mice compared to 
their littermates (Pollonini et al., 2008), suggesting a possible attempt of the nervous system 
to protect itself from the neuronal loss that occurs in DS throughout development. Enhanced 
secretion of NT-3 has been also found in the hippocampus of adult Ts65Dn mice (Pollonini et 
al., 2008). As NT-3 expression by cortical neurons serves to attract basal forebrain 
cholinergic projections (Robertson et al., 2006), an increase in NT-3 may be a compensatory 




Overall, substantial morphological and molecular evidence demonstrates that trisomy 
disrupts CNS development and accelerates age-related neurodegeneration of individuals with 
DS and Ts65Dn mice in a very similar manner, resulting in specific cognitive, behavioral, 
motor and sensory deficits. This clearly illustrates that the Ts65Dn mouse is an excellent 
model for better understanding of pathological processes underlying DS and preclinical 
evaluation of new therapeutic strategies. 
 
1.4. Altered synaptic plasticity and disruption of excitatory-inhibitory 
balance as a central mechanism of neurophysiological impairments in 
Down syndrome    
Learning and memory, key cognitive processes affected by DS, have been strongly associated 
with synaptic plasticity mechanisms (Bliss and Collingridge, 1993, Hofer and Bonhoeffer, 
2010). Synaptic plasticity refers to the physiological ability of synapses to alter their 
structure, composition or function in response to changes in neural activity. Depending on the 
timing and strength of pre- and postsynaptic activity, synapses can either be strengthened or 
weakened, providing a potential mechanism for memory formation and storage (Dan and 
Poo, 2006). The connection between synaptic plasticity and learning and memory is typically 
studied within the hippocampus, as this brain region is critically involved in acquisition, 
storage and recall of spatial information (Nadel and Bohbot, 2001, Kesner, 2007, Moser et 
al., 2008). Consequentially, any structural or functional abnormalities in hippocampus that 
limit the capability of synapses to undergo plastic changes would be expected to compromise 
spatial cognition. The described morphological and behavioral alterations associated with 
trisomic hippocampus, like dendritic pathology (Becker et al., 1986, Takashima et al., 1989) 
and impairments in spatial learning and memory (Pennington et al., 2003, Edgin et al., 2010), 
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suggest an ineffective synaptic plasticity in DS. There is evidence indicating that plasticity is 
reduced also in the motor cortex of DS individuals (Battaglia et al., 2008). Moreover, 
functional MRI (fMRI), performed during cognitive processing tasks involving multiple brain 
regions, reveals abnormal neural activation patterns in DS children and young adults (Losin 
et al., 2009, Jacola et al., 2011). These data suggest that an impairment of synaptic plasticity 
may not be exclusively an hippocampal phenomenon, but a general characteristic of DS 
brain. Consistent with this idea is also the general defect in synaptogenesis that starts to be 
evident from the fetal period (Becker et al., 1991) and persists until adult age (Petit et al., 
1984, Takashima et al., 1994, Weitzdoerfer et al., 2001). Since it is very difficult to evaluate 
synaptic function in humans, the animal models have provided important insights into the 
neurobiology of aberrant plastic mechanisms in DS.   
The best established experimental models for investigating the synaptic base of 
learning and memory in rodents are long-term potentiation (LTP) and long-term depression 
(LTD), that refer to long-lasting up- or downregulation of synaptic strength, respectively, 
after an appropriate electrical stimulus of hippocampal circuits in the brain slice preparation. 
It is conventionally believed that the ability of hippocampal circuits to undergo LTP and LTD 
is necessary for the processes of learning and memory; thus, alteration in the expression of 
these two model of synaptic plasticity is considered an electrophysiological correlate of 
cognitive deficits.  
Multiple lines of evidence indicate that synaptic plasticity is altered in adult Ts65Dn 
mice. The phenomenon of LTP has been studied in detail in this mouse model and its 
reduction has been reported in the hippocampal CA1 and DG regions (Siarey et al., 1997, 
Kleschevnikov, 2004, Costa and Grybko, 2005, Das and Reeves, 2011, Kleschevnikov et al., 
2012). Importantly, LTP abnormalities have been also observed in various rodent models of 
other forms of developmental ID (DID) (Costa et al., 2002, Asaka et al., 2006, Moretti et al., 
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2006, Guy et al., 2007) and AD (Chapman et al., 1999, Larson et al., 1999, Moechars et al., 
1999, Origlia et al., 2006, Houeland et al., 2010), indicating that the impairment of synaptic 
plasticity in the case of DS may underlie both ID emerging during childhood and additional 
cognitive decline due to precocious AD in adulthood. In addition to LTP failure, abnormal 
augmentation of LTD has been reported from hippocampal slices of Ts65Dn mice (Siarey et 
al., 1999, Scott-McKean and Costa, 2011) further strengthening a link between alteration of 
synaptic plasticity in hippocampus and poor cognitive performance displayed by this DS 
animal model.  
The breakthrough discovery in this field was the demonstration that the reduction of 
LTP in adult Ts65Dn mice is due to an imbalance between excitatory and inhibitory inputs to 
the hippocampus. Acute additions of inhibitors of GABAA receptors in the brain slice 
preparation rescued LTP expression in the DG (Kleschevnikov, 2004), indirectly pointing at 
excessive hippocampal inhibition in trisomic mice. More direct evidence for increased 
GABAergic transmission came from the recent report of significantly increased evoked 
inhibitory postsynaptic currents (IPSCs) mediated by  GABAA and GABAB receptors in the 
DG, suggesting an enhancement in presynaptic GABA release probability (Kleschevnikov et 
al., 2012). While this study indicates the involvement of both types of GABA receptors in the 
modulation of DG synaptic efficiency, another recently published paper reported that in the 
CA1 region the balance between GABAA and GABAB receptor-mediated inhibition is shifted 
in favor of the latter in a pathway-specific manner (Best et al., 2012). Increased GABAB 
receptor-mediated signaling has been linked to DS specific triplication of G-protein-activated 
inwardly rectifying potassium channel 2 (Girk2) gene. The Girk channels are the postsynaptic 
effectors of GABAB receptors and it has been hypothesized that overexpression of Girk2 gene 
may be directly responsible for LTP failure in trisomic mice (Harashima et al., 2006, Best et 
al., 2007). In line with this functional evidence for an increased inhibitory tone in the 
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hippocampus of Ts65Dn mice are the above discussed changes in synaptic structure that 
favor GABAergic transmission (Belichenko et al., 2004, Belichenko et al., 2009b), 
supporting the view that hippocampal LTP failure and increased inhibition may be a key 
mediator of cognitive dysfunction in DS.  
Given that DS patients demonstrate susceptibility to epilepsy (Stafstrom, 1993),  it has 
been speculated that the increment in the level of inhibition could reflect an attempt by the 
system to cope with over-excitation (Pérez-Cremades et al., 2010). However, it has been 
demonstrated that the origin of altered excitatory/inhibitory ratio dates back to the prenatal 
period, suggesting that excessive inhibition is not a compensatory mechanism but rather the 
direct pathological output of abnormal cortical development in Ts65Dn mice. During the 
prenatal period, longer cell cycle durations in the ventricular and subventricular zone of 
Ts65Dn might lead to reduced overall production of excitatory neurons at the cortical plate, 
with a delay in their arrival and differentiation (Haydar et al., 1996, Cheng et al., 2004, 
Chakrabarti et al., 2007). It has been shown that this perturbation of neural developmental 
pathways may be due to overexpression of the dual-specificity tyrosine phosphorylation-
regulated kinase 1A (Dyrk1a) gene (Altafaj et al., 2001, Martinez de Lagran et al., 2004). The 
Dyrk1a gene encodes a kinase that is strongly expressed in neural structures, especially 
within neural precursor populations during embryonic neurogenesis (Okui et al., 1999, 
Hammerle et al., 2002, Hammerle et al., 2008) and interacts with a wide variety of growth 
factors, transcription factors and cell-cycle regulatory proteins known for their roles in neural 
cell proliferation and specification (Yang et al., 2001, Maenz et al., 2008, Fernandez-
Martinez et al., 2009, Lepagnol-Bestel et al., 2009, Tejedor and Hammerle, 2011). 
Additionally, prenatal overexpression of the Olig1 and Olig2 transcription factor genes in the 
germinal zones of the ventral telencephalon results in an elevated rate of cell production from 
the neural precursors and leads to increased number of parvalbumin- and somatostatin-
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expressing interneurons in the cerebral cortex and hippocampus of Ts65Dn mice (Chakrabarti 
et al., 2010). Olig1 and Olig2 genes are typically expressed in the progenitors of the medial 
ganglionic eminence,  the specific germinal zone for parvalbumin- and somatostanin-
expressing interneurons, and not in the progenitors of the lateral and caudal ganglionic 
eminence specific for calretinin-expressing interneurons, resulting in an increased 
neurogenesis for only the first two specific groups of interneurons (Chakrabarti et al., 2010). 
Taken together, these impairments in neurogenesis alter the ratio between excitatory and 
inhibitory neurons leading to the onset of excessive inhibition during early phases of prenatal 
forebrain development (Haydar and Reeves, 2012).  
A fine tuning of the ratio between excitatory and inhibitory drive within neural 
networks is necessary for an appropriate function of both the developing and mature brain 
(Bradford, 1995, Thompson et al., 1996, Fagiolini and Hensch, 2000, Jamain et al., 2003, 
Haydar, 2005, Sale et al., 2007b). Anatomical and physiological evidence from all so far 
tested species indicates that in the neocortex inhibitory circuits mature later and slower than 
excitatory connections (Blue and Parnavelas, 1983, Luhmann and Prince, 1991, Benevento et 
al., 1992, Guo et al., 1997, Micheva and Beaulieu, 1997, Gao et al., 2000, Mower and Guo, 
2001, Murphy et al., 2005). This gradual maturation of GABAergic inhibition appears to be a 
key determinant in the initiation and closure of critical periods (CPs) of experience-dependent 
developmental plasticity in cortical circuits (Huang et al., 1999). CPs are time windows in 
early postnatal development characterized by heightened brain plasticity, during which 
experience can produce permanent, large-scale modifications in neuronal circuits (Berardi et 
al., 2000, Hensch, 2004). By their ability to control the onset and offset of CPs, GABAergic 
interneurons may directly affect how experience shapes brain connections during early life 
and adolescence. The capacity for adaptive change of neural networks wanes after the closure 
of CPs and the limited ability of adult circuits to undergo plastic responses is also controlled 
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by proper inhibitory drive (Harauzov et al., 2010, Sale et al., 2010). Moreover, beside the 
engagement in the control of neuronal excitability, a proper GABAergic tone is also required 
for the generation of temporal synchrony and oscillatory behavior among networks of 
pyramidal neurons. Such oscillations within and across neural systems are believed to serve 
various complex functions, such as memory, perception and movement initiation 
(Chattopadhyaya and Cristo, 2012).  
Based on this important role of finely tuned GABA tone in modulating network 
dynamics of neocortical circuits, the mismatch in the maturation of excitation and inhibition 
and the long-term changes in neural excitability in the DS brain may affect multiple neural 
functions (Baroncelli et al., 2011). The results from Ts65Dn mice clearly illustrate that an 
enhanced GABAergic inhibition in hippocampal circuits leads to prominent reductions of 
LTP levels. It has been hypothesized that the impairment of this form of activity-dependent 
plasticity displayed by Ts65Dn mice may be actually linked to dysfunctional homeostatic 
plasticity (Fernandez and Garner, 2007). Homeostatic plasticity refers to remodeling of 
neural connections in response to chronic excitation or inhibition of neuronal networks and it 
occurs over broad time scales to protect the system from excessive activity of excitatory or 
inhibitory neurons (Turrigiano, 1999, Turrigiano and Nelson, 2004, Davis, 2006). Absence of 
such resetting of neural activity in DS brain as a consequence of excessive inhibition from 
early stages of development may result in the establishment of neural circuits incapable to 
experience synaptic plasticity and properly adapt to novel demands of the system.   
It has been suggested that therapeutic strategies targeting over-inhibition in DS should 
be based on the concept of adaptive change in order to safely and permanently counteract 
excitatory-inhibitory imbalance and promote homeostatic plasticity. The concept of adaptive 
change alludes to long-term alterations at molecular, physiological, anatomical and 
behavioral levels that occur not through acute modifications of synaptic function, but through 
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lasting alterations within neural circuits (Fernandez and Garner, 2007). This possibility for 
DS treatment has been successfully explored on Ts65Dn mice by administrating a non-
epileptic dose of noncompetitive GABAA antagonists. It has been found that chronic, but not 
acute, treatment resulted in amelioration of learning and memory deficits in Ts65Dn mice, 
accompanied by rescue of impaired LTP in the DG (Fernandez et al., 2007). This 
pharmacological approach led to a persistent recovery of Ts65Dn cognition and LTP lasting 
for several months after the cessation of treatment, indicating that this therapeutic protocol 
was able to elicit neuroadaptive processes promoting both homeostatic and synaptic plasticity 
(Fernandez et al., 2007).  
Altogether these data strongly suggest that dysfunctional synaptic plasticity may be 
the major determinant of DS. A growing body of evidence demonstrates the tight link 
between synaptic failure and disrupted excitatory-inhibitory balance driven by molecular and 
cellular perturbations associated with overexpression of genes involved in forebrain 
development. Theoretically, the early onset of excessive inhibition in DS brain may be 
prevented by prenatal interventions aiming at the correction of such genetic perturbations, but 
the application of this gene-based therapy on human fetuses is not feasible at the present due 
to technical limitations and ethical concerns (Haydar and Reeves, 2012). On the other hand, 
over-inhibition as the final outcome of mixed gene dosage effects during early development 










EFFECTS OF ENVIRONMENTAL ENRICHMENT AND 
ENVIROMIMETICS ON BRAIN IN HEALTH AND DISEASE 
 
The development and maturation of the mammalian brain are governed by complex genetic 
and epigenetic programs that enable temporal and spatial integration of molecular and 
cellular signals necessary for the construction of appropriate neural networks. Once formed, 
neural circuitries undergo continuous refinements through motor, sensory, social and 
cognitive interactions with the environment during the whole lifespan. In this way, genes and 
environment act together to establish and maintain optimal brain function. Thus, any 
modification of this complex gene-environment interaction would be expected to have  
profound impact on CNS. This chapter will address the spectrum of beneficial effects elicited 
by environmental enrichment (EE) paradigm. EE refers to the housing conditions that enable 
enhanced cognitive, motor, social and sensory stimulation of animals in comparison with 
standard laboratory environment (Rosenzweig and Bennett, 1996, van Praag et al., 2000, Sale 
et al., 2009).  
It has been clearly demonstrated that EE is able to dramatically affect the functional, 
anatomical and molecular properties of the CNS, both during the CPs and in adulthood 
(Baroncelli et al., 2010a). Important insights into the mechanisms underlying these 
remarkable effects have been provided by studies focused on the visual system (Sale et al., 
2009). At early stages of brain development, EE triggers a marked acceleration in the 
maturation of the visual system with enhanced maternal care acting as a fundamental 
mediator of the enriched experience in the newborn. In the adult brain, EE stimulates 
plasticity in the cerebral cortex, promoting the recovery of visual functions in amblyopic 
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animals. The broad spectrum of neural effects exerted by EE is considerable given that it 
activates multiple molecular responses including reduced intracerebral inhibition, enhanced 
neurotrophin expression and epigenetic changes at the level of chromatin structure.  
These results shed new light on the potential of EE as a non invasive strategy to 
ameliorate deficits in the development of the CNS and to treat neurodegenerative disorders 
associated with aging (Nithianantharajah and Hannan, 2006, Baroncelli et al., 2010a). 
Moreover, it has been proposed that the molecular and cellular systems which mediate the 
therapeutic effects of EE may provide novel targets for development of new pharmacologic 
therapies. Based on this assumption, a novel class of therapeutics, called enviromimetics, has 
been introduced as a promising therapeutic approach for a wide range of nervous system 
disorders (McOmish and Hannan, 2007). 
 
2.1. Neural consequences of environmental enrichment  
EE is classically defined as “a combination of complex inanimate and social stimulation” 
(Rosenzweig et al., 1978). Enriched animals are reared in large groups and housed in 
spacious cages where running wheals and a variety of differently shaped objects are 
introduced and changed frequently. In this way the animals experience a multi-
sensory/cognitive stimulation, increased physical activity and enhanced social interactions 
that improve the quality of animals’ life and promote their natural explorative behaviors. 
Thus, EE has been created as a gain-of-function paradigm that allows to understand how 
increased levels of environmental stimulation may influence brain development and 
plasticity.  
EE exerts profound effects on the adult healthy brain. The most prominent outcome of 
this experimental paradigm is an enhancement of neural plasticity, the ability of the nervous 
system to change in response to experience. While neural plasticity is a fundamental property 
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of the brain, it has been shown that  EE is able to elicit structural and functional changes in 
the brain that promote brain plasticity (van Praag et al., 2000).  
Multiple studies reported that EE is able to modify animals’ behavior leading to an 
improvement in complex cognitive functions, particularly learning and memory (Rampon and 
Tsien, 2000), and positively affecting the animals’ emotional and stress reactivity (Chapillon 
et al., 2002). In line with these ameliorations of cognitive performance is the increased 
potential for synaptic refinement displayed by enriched animals, as illustrated by facilitation 
of LTP induction in the hippocampus (van Praag et al., 2000).  
This functional improvement is accompanied by prominent changes at the anatomical 
level. Robust increments in cortical thickness and weight and modifications of neuronal 
morphology, including increased dendritic arborisation, number of dendritic spines, synaptic 
density and postsynaptic thickening, have been observed in several regions of the brain, 
particularly in the hippocampus and the occipital cortex (Mohammed et al., 2002). Moreover, 
exposure to EE enhances hippocampal neurogenesis and the integration of newly born cells 
into functional circuits, which in turn may increase the existing potential of mature brain for 
learning and memory (van Praag et al., 2000).  
At the molecular level, EE causes a significant change in the expression of a large set 
of genes involved in neuronal structure, excitability, synaptic transmission and plasticity 
(Rampon et al., 2000). Further, EE modulates the synthesis and secretion of neurotrophic 
factors throughout the brain and affects the cholinergic, serotoninergic and noradrenergic 
signaling (Rosenzweig and Bennett, 1969, Rasmuson et al., 1998, Ickes et al., 2000, Naka et 
al., 2002). Although the major part of EE studies have been mainly focused on rodents, 
similar effects have been reported in several species of mammals, such as gerbils, ground 
squirrels, rabbits, cats and primates (Rosenzweig and Bennett, 1969, Cornwell and Overman, 
1981, Hansen and Berthelsen, 2000, Kozorovitskiy et al., 2005, Jansen et al., 2009).   
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2.2. Influence of environmental enrichment on brain development  
Despite the large body of evidence concerning the effects of EE on the adult brain, until 
recently the influence of an enhanced stimulation on the developmental physiology and 
plasticity of the CNS has remained only poorly investigated. This topic has been addressed  
in  the past few years with a series of studies focusing on the visual system, the paradigmatic 
model for studying experience-dependent plasticity, as it allows easy manipulations of visual 
experience and follow-up of the elicited changes at the molecular, cellular and anatomical 
level. Although the maturation of visual system starts before eye opening and the initial 
targeting of neural connections is subjected to either genetic programs or spontaneous 
activity, a proper development of the visual system requires sensory experience (Crowley and 
Katz, 2002, Leamey et al., 2009). A total absence of sensory input leads to a delay in the 
functional and anatomical maturation of the visual cortex as illustrated by a spectrum of 
serious physiological deficits, like immature ocular dominance (OD) distribution in the 
primary visual cortex (V1) and lower VA, displayed by adult animals reared in darkness 
(dark rearing, DR) from birth (Fregnac and Imbert, 1978, Timney et al., 1978, Benevento et 
al., 1992, Fagiolini et al., 1994). Experience-dependent plasticity in V1 is typically 
investigated throughout analysis of binocularity expressed by the OD index. More precisely, 
OD plasticity refers to the rapid change in visual cortex physiology resulting from 
unbalanced inputs from the two eyes and it is easily induced only in developing brain. The 
first demonstration of this phenomenon has been provided by Hubel and Wiesel, who 
reported that reduced input from one eye by lid suture (monocular deprivation, MD) during 
development results in the loss of cortical responses to closed eye and gain of activity of 
neurons preferentially stimulated by the open eye. Consequentially, this visual manipulation 
dramatically affects the binocularity of V1 and makes the deprived eye amblyopic, with a 
significantly reduced VA and blunted contrast sensitivity (Wiesel and Hubel, 1963, Hubel 
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and Wiesel, 1970). Based on this experiment, the effects of MD and the existence of a CP for 
OD plasticity have been subsequently described in different species of mammals (Van 
Sluyters and Stewart, 1974, Hubel et al., 1977, Emerson et al., 1982, Fagiolini et al., 1994, 
Gordon and Stryker, 1996, Issa et al., 1999). 
The most relevant result regarding the effects of EE from birth on visual system 
development is a marked acceleration in the maturation of VA respect to animals reared in 
standard conditions (Prusky et al., 2000, Cancedda et al., 2004, Sale et al., 2004, Landi et al., 
2007a, Landi et al., 2007b). Moreover, rearing animals from birth in EE results in an 
accelerated decline of white matter-induced LTP (WM-LTP), a well-established in vitro 
model of developmental plasticity (Kirkwood et al., 1995), in visual cortical slices after theta-
burst stimulation (Cancedda et al., 2004). Importantly, EE is also able to compensate the 
deficits caused by a complete lack of visual experience from birth. Namely, DR rats 
maintained in EE conditions show a normal VA development and closure of the CP for OD 
plasticity (Bartoletti et al., 2004). Similar findings have been reported in the auditory system. 
It has been found that pre-weaning EE improves spatial localization abilities and enhances 
directional sensitivity of A1 neurons (Cai et al., 2009), although it remains still unexplored 
whether exposure to EE conditions counteract the delay in A1 maturation provoked by white 
noise rearing.  
Retina development is also affected by high levels of environmental stimulation. EE 
accelerates the segregation of retinal ganglionic cell (RGC) dendrites into ON and OFF 
sublaminae and the maturation of retinal acuity during development (Landi et al., 2007a, 
Landi et al., 2007b). Strikingly, it has been shown that retinal development is profoundly 
affected by EE also during embryonic life. Exposing pregnant females to EE is able to 
accelerate structural processes critical for retinal maturation, such as the migration of neural 
progenitors and the time-course of naturally occurring cell death in the RGC layer (Sale et al., 
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2007a), indicating that even indirect forms of environmental stimulation may influence 
development of the nervous system during prenatal life. The influence of increased female 
stimulation during pregnancy is not restricted only to the visual system of their offspring. 
Voluntary wheel running of pregnant mice leads to a two-fold increase in hippocampal 
precursor-cell proliferation in their pups (Bick-Sander et al., 2006), while maternal swimming  
improves short-term memory abilities of the newborns (Lee et al., 2006). 
BDNF and the insulin-like growth factor (IGF-I) have emerged as crucial molecular 
mediators of the EE effects on the development of visual system. Mice raised in EE showed 
increased levels of the BDNF protein in their visual cortex at P7 (Cancedda et al., 2004, Sale 
et al., 2004). Higher BDNF levels in EE pups were shown to trigger the maturation of the 
inhibitory GABAergic system, which in turn, by affecting the formation of receptive field 
and synaptic plasticity, may determine both the accelerated development of VA and the 
decline of cortical plasticity (Huang et al., 1999, Cancedda et al., 2004, Sale et al., 2004). 
Similarly to BDNF increase in mice, IGF-I expression is higher at P18 in the visual cortex of 
EE rats. Importantly, exogenous IGF-I supply mimics, whereas blocking of its action 
prevents, the EE effects on VA maturation. As in the case of BDNF, these effects are 
mediated by activation of the inhibitory system, as GABAergic interneurons respond to IGF-I 
with a glutamic acid decarboxylase 65 (GAD65) increase in their synaptic terminals (Ciucci 
et al., 2007). IGF-I emerged also as a key player in the mediation of the effects of maternal 
enrichment on prenatal retinal development. The previously described anatomical 
modifications of retinal structure are accompanied by a marked increase of IGF-I levels in the 
retinas of EE pups and in the maternal milk. Furthermore, if IGF-I is infused during late 
pregnancy to non-EE females, their foetuses undergo all the reported changes elicited by EE, 
while neutralization of IGF-I action in EE mothers prevents the effects of maternal EE on 
retinal development (Sale et al., 2007a).  
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The aforementioned studies of the effects of EE on retinal development in the 
newborn have suggested that BDNF and IGF-I may activate the same intracellular pathways. 
It has been revealed that retinal levels of both proteins are precociously increased in the RGC 
layer of developing EE rats and blocking either IGF-I or BDNF action in EE animals 
counteracts the acceleration of retinal maturation (Landi et al., 2007a, Landi et al., 2007b, 
Landi et al., 2009). Importantly, BDNF turned out to be a downstream target of IGF-I (Landi 
et al., 2009). BDNF and IGF-I signalling may eventually converge on the activation of 
intracellular pathways, leading to the phosphorylation of the transcription factor CREB. The 
wave of CREB/CRE-mediated gene expression in the visual cortex is accelerated in EE mice 
and chronic administration of rolipram, a drug that increases the phosphorylation of CREB, 
partially mimic the EE outcome on VA maturation in non-EE animals (Cancedda et al., 
2004). Thus, activation of CREB/CRE transcription pathway was identified as a key 
molecular target of EE in the visual system during development. 
  
2.3. Maternal care, tactile stimulation and visual system development in 
environmental enrichment conditions  
The aforementioned studies demonstrate that the CNS responds readily to environmental 
manipulations already at very early stages of development. However, given that during the 
first days of life rodents spend their whole time in the nest, it was crucial to understand how 
EE is able to elicit its marked effects on visual system development, in a period when a direct 
interaction between the pup and the external environment is missing. During the early 
postnatal period, the mother is the most important source of sensory experience; thus, it has 
been soon realized that differences in maternal behaviour between EE and non-EE conditions 
could be a fundamental  mediator of the earliest effects of EE on visual system development. 
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A detailed quantitative study of maternal behaviour in different environmental conditions has 
demonstrated that enriched pups receive higher levels of maternal care when compared with 
standard-reared pups (Sale et al., 2004). More specifically, EE newborns experience a 
continuous physical contact due to the presence of adult females in the nest and also receive 
increased levels of active tactile stimulation in the form of licking and stepping (Sale et al., 
2009). Beside the visual cortex, increased amounts of maternal care can also influence the 
development of hippocampus, affecting molecular factors crucial for plasticity, such as 
BDNF and NMDA receptors (Liu et al., 2000).  
Tactile stimulation has been identified as a crucial component of maternal care during 
early postnatal period. It has been demonstrated that daily artificial tactile stimulation of 
newborn rats is effective as well as EE in accelerating the maturation of visual functions, in 
particular VA. Moreover, this protocol of tactile stimulation increases IGF-I levels in the 
visual cortex exactly at P18, as reported in EE animals, and blocking IGF-I action prevents 
the effects of massage on VA development (Guzzetta et al., 2009). Tactile stimulation may 
also successfully compensate the deleterious effects of inadequate maternal care on 
developing pups. It has been shown that artificial massage is able to counteract the negative 
consequences of different types of perinatal stress on neonates growth, as illustrated by 
rescue of hormonal balance, normalization of hypothalamus-pituitary-adrenal axis activity 
and BDNF expression in massaged newborns (Schanberg and Field, 1987, Burton et al., 
2007, Chatterjee et al., 2007). Altogether, these results provide a remarkable example of 
cross-modal plasticity by which an increased input in a single modality reverberates as a 
driving force for the whole brain (Baroncelli et al., 2010a).  
Strikingly, brain development of healthy preterm infants is also highly responsive to 
tactile stimulation. Daily massage therapy of preterm neonates induces an earlier shortening 
of the interbust intervals in the EEG, a robust index of the developmental stage of the brain, a 
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significantly reduction in the latency of flash VEPs and an increase in VA that outlasts the 
end of the treatment, all together indicating an accelerated CNS maturation (Guzzetta et al., 
2009). Moreover, massaged infants displayed increased levels of plasma IGF-I, suggesting 
that this molecule has a critical role in mediating the effects of an enhanced sensory 
stimulation also in humans. These findings underline the importance of environmental 
stimulation for early postnatal CNS development and promote the implementation of 
massage therapy in the protocols of intensive care for preterm babies as a potential strategy to 
counteract the onset of neurological pathologies associated with a precocious delivery 
(Guzzetta et al., 2009). 
 
2.4. Rejuvenating the adult brain 
The developing brain is characterized by high levels of plasticity that dramatically decline 
after the end of CPs. This limits the capability of the adult brain to effectively rearrange its 
circuits in response to external stimuli. The visual system has emerged again as a valid 
experimental model for a better understanding of  neural plasticity limitations in adulthood. It 
is well known that early abnormal visual experience caused by anisometropia (unequal 
refractive power in the two eyes), strabismus (abnormal alignment of one or both eyes), 
congenital cataract or, in animal models MD, results in a functional imbalance between the 
two eyes leading to amblyopia, a widely diffused pathology in the human population (Holmes 
and Clarke, 2006). Amblyopia compromises numerous aspects of visual processing resulting 
in a dramatic loss of VA, deficits in stereopsis and poor contrast sensitivity in an apparently 
healthy eye (Lewis and Maurer, 2005, Levi, 2006). The classic hallmarks of amblyopia are 
recapitulated in rodent models and include permanent loss of VA in the affected eye and a 
pronounced OD shift of visual cortical neurons in favour of the normal eye (Timney, 1983, 
Maurer et al., 1999, Prusky et al., 2000, Prusky and Douglas, 2003, Kiorpes, 2006). Based on 
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clinical experience it has been widely accepted that reinstatement of visual functions is 
possible only if amblyopia is diagnosed and corrective therapy is started early in development 
(Wu and Hunter, 2006).  
Recent studies in rodents have revealed a previously unsuspected potential for  
recovery of visual processing well after the end of the CP, suggesting a possibility to treat 
amblyopia even in adulthood (Spolidoro et al., 2009). It has been demonstrated that a brief 
exposure, two-three weeks, of adult amblyopic rats to EE is sufficient to completely rescue  
both VA and OD (Sale et al., 2007b). In vivo brain microdyalisis revealed that the 
improvement of visual functions is accompanied with a threefold reduction in the basal levels 
of GABA in the visual cortex. Moreover, the decreased cortical inhibition associated with EE 
treatment enabled induction of WM-LTP in visual cortical slices (Sale et al., 2007b), a form 
of synaptic plasticity that is normally occluded in adulthood as a result of the maturation of 
inhibitory circuits (Kirkwood et al., 1995, Huang et al., 1999). Restoration of plasticity is 
totally prevented by benzodiazepine cortical infusion during the period of enhanced 
stimulation, indentifying the reduction of inhibitory drive as a key molecular mechanism at 
the basis of heightened plasticity levels induced by EE (Sale et al., 2007b). This data 
represent an additional evidence for the crucial role of the excitatory-inhibitory balance of 
cortical activity in regulating plasticity in the developing and adult brain (Huang et al., 1999, 
Fagiolini and Hensch, 2000, He et al., 2006, He et al., 2007). The reduction of cortical 
inhibition in the visual cortex of enriched rats is paralleled by an increased expression of 
BDNF (Sale et al., 2007b), a neurotrophic factor critical for experience-dependent plasticity 
(Huang et al., 1999). The potential of EE to reinstate juvenile-like plasticity in the adult 
visual cortex is not limited to its effects on amblyopia. Remarkable reactivation of OD 
plasticity in response to MD, accompanied by a marked reduction of the inhibitory tone and 
an increase in BDNF signalling in the visual cortex, has been also reported in healthy 
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enriched rats (Baroncelli et al., 2010b). Moreover, it has been demonstrated that EE elicits a 
twofold enhancement of serotoninergic transmission in the visual cortex. Importantly, 
infusion of a serotonin synthesis inhibitor not only blocks OD plasticity in response to MD, 
but also completely counteracts the effects produced by EE on GABAergic inhibition and 
BDNF synthesis, indicating a critical role for this transmitter in triggering the plastic changes 
provoked by enhanced stimulation (Baroncelli et al., 2010b).  
EE in adulthood also influences the regulation of gene expression. One mechanism of 
action is the activation of specific transcription factors. Enhancement of BDNF intracellular 
signalling following EE stimulates phosphorylation and activation of CREB (Finkbeiner et 
al., 1997, Pizzorusso et al., 2000, Ratto and Pizzorusso, 2006), which plays a pivotal role in 
various forms of plasticity in the visual cortex (Pham et al., 1999a, Mower et al., 2002, Pham 
et al., 2004) and other brain structures (Lonze and Ginty, 2002). EE regulates gene expression 
also at the epigenetic level, resulting in the enhancement of histone acetylation in the 
hippocampus and neocortex, a process that generally promotes gene transcription (Fischer et 
al., 2007). A similar relationship between histone acetylation and EE may be present in the 
adult visual system, as pharmacological treatment with inhibitors of histone deacetylases 
restores OD plasticity (Putignano et al., 2007). On the basis of these results, a possible 
involvement of epigenetic mechanisms in the control of CPs for OD plasticity has been 
suggested (Medini and Pizzorusso, 2008, Fagiolini et al., 2009).  
Beside modulation of the excitatory/inhibitory balance and gene expression, EE 
affects plasticity in the adult brain also through alteration of synaptic structures. It has been 
reported that amblyopic rats exposed to EE have reduced density of chondroitin-sulfate 
proteoglycan (CSPG) perineuronal nets (PNNs) in the visual cortex (Sale et al., 2007b). This 
is consistent with pharmacological studies that have reported reactivation of OD plasticity in 
monocularly deprived adult rats after removal of crucial components of PNNs from the 
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mature extracellular matrix by means of the enzyme chondroitinase ABC, suggesting that 
CSPGs exert a powerful repressive control on adult plasticity (Pizzorusso et al., 2002, 
Pizzorusso et al., 2006). Moreover, this treatment counteracted the consequences of early 
visual deprivation on both VA and binocularity. These functional effects are accompanied by 
a normalization of dendritic-spine density indicating that removal of CSPGs may favour 
remodelling of synaptic contacts onto visual-cortex pyramidal neurons (Pizzorusso et al., 
2006). A very recent study reported that EE increases density and turnover of dendritic spines 
in the somatosensory cortex (Jung and Herms, 2012). In vivo microscopy shown that EE 
induces both transient and long-lasting gain of novel spines. Based on these results, authors 
have proposed that the cognitive benefits seen in environmental-enriched animals might be a 
consequence of both, a higher connectivity of the neuronal network due to more established 
synapses and an enhanced flexibility due to more transient spines (Jung and Herms, 2012). 
 
2.5. Beneficial effects of environmental enrichment on functional outcome 
in models of brain disorders  
The aforementioned studies focused on the visual system have provided important insights 
into the nature of the neural benefits of EE and offered a new hope for amblyopia treatment 
in adulthood. However, the positive effects of this paradigm exceed sensory processing and 
occur also in the areas of motor performance, social-emotional behaviour and learning and 
memory. Deficits in these functional domains may be diagnosed in neurodevelopmental and 
neurodegenerative disorders and are often associated with an altered potential of neural 
circuits to undergo synaptic modifications (Battaglia et al., 2007, Bagetta et al., 2010, Orth et 
al., 2010, West and Greenberg, 2011, Zoghbi and Bear, 2012). Given that EE normalizes 
brain plasticity through multiple mechanisms, such as correction of excitatory/inhibitory 
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disbalance, enhancement of neurotrophin signalling and epigenetic modifications, it is not 
surprising that this non-pharmacological strategy may be successfully employed to prevent, 
delay and/or ameliorate the symptoms of many neurodevelopmental and neurodegenerative 
disorders, despite their quite various aetiologies (Nithianantharajah and Hannan, 2006, 
Baroncelli et al., 2010a).  
 Significant deterioration of neural functions may occur in apparently healthy 
individuals during the aging process. It has been proposed that cognitive and physical 
stimulation through EE may be neuroprotective in the elderly by preventing the age–related 
cognitive decline and reducing the risk of neurodegenerative disease (La Rue, 2010). It has 
been shown that long-term continuous EE improves performance of healthy aged mice in 
MWM and radial arm maze tasks (Bennett et al., 2006). Similarly, old rats housed in enriched 
conditions for their whole life perform better on a delayed sample to match task (Soffie et al., 
1999). However, recent evidence suggests that it is necessary to expose animals to EE before 
the median of their lifespan in order to gain the protective effects against the age-related 
cognitive decay (Freret et al., 2012).  
Beside this important preventive potential of EE, there are numerous studies 
demonstrating the remarkable capacity of this paradigm not only to delay onset and slow 
progression of degenerative brain disorders, but also to rescue their cognitive phenotype. The 
first demonstration that this is the case has come from studies on Huntington's disease (HD) 
(van Dellen et al., 2000), a genetic brain syndrome manifested by cognitive deficits leading to 
dementia, psychiatric disorders and motor symptoms due to a progressive process of 
neurodegeneration in the cerebral cortex and striatum (Laviola et al., 2008). Mouse models of 
HD display cognitive impairment together with abnormal synaptic plasticity and decreased 
hippocampal neurogenesis (Murphy et al., 2000, Lazic et al., 2004, Mazarakis et al., 2005). 
EE has been shown to delay the onset and progression of motor symptoms of transgenic 
55 
 
models of HD (van Dellen et al., 2000, Hockly et al., 2002, Spires et al., 2004) as well as 
their cognitive deficits, accompanied by rescue of synaptic plasticity and neurogenesis (Grote 
et al., 2005, Nithianantharajah et al., 2008).  
Another important example of the therapeutic effectiveness of EE comes from 
preclinical research focused on transgenic models of AD. It has been demonstrated that EE 
enhances cognitive performance in a variety of AD transgenic mice (Berardi et al., 2000, 
Arendash et al., 2004, Jankowsky et al., 2005, Wolf et al., 2006, Costa et al., 2007, 
Cracchiolo et al., 2007). In addition to cognitive improvement, some studies have reported 
positive effects of EE on adult hippocampal neurogenesis (Wolf et al., 2006, Herring et al., 
2009, Mirochnic et al., 2009), angiogenesis and Aβ clearence (Herring et al., 2009). Finally, 
it has been shown that EE also upregulates the expression of trophic factors, such as NT-3, 
BDNF, IGF-I and VEGF, in the hippocampus (Wolf et al., 2006) and attenuates pro-oxidative 
processes (Herring et al., 2009) in AD mouse models. Thus, EE profoundly alters cognitive, 
cellular and molecular aspects of pathogenetic processes associated with AD.  
 An important line of research deals with the potential therapeutic effects of EE on 
experimental models of DID. There is evidence demonstrating that EE may improve 
functional outcome not only in animal models of diseases resulting from alteration of 
environmental factors during early phases of development, such as Fetal Alcohol Spectrum 
Disorders (FASDs), but also in the case of genetically programmed syndromes, like RS and 
DS (Reynolds et al., 2010).  
FASDs can occur in children whose mothers consume alcohol during pregnancy and 
behavioural manifestations of disease generally include deficits in cognitive performance, 
executive functioning, and sensory-motor functions (Jirikowic et al., 2008, Kodituwakku, 
2009). Rodent offspring whose mothers are exposed to ethanol display similar deficits 
accompanied by hippocampal damage and LTP failure (Puglia and Valenzuela, 2009, 2010). 
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It has been shown that post-weaning exposure to EE improves spatial learning and 
normalizes atypical performance on a structured learning task in affected mice (Hannigan et 
al., 1993, Wainwright et al., 1993).  
RS is a genetic disorder characterized by a pattern of apparently typical development 
for the first few years of life, followed by a progressive decline in motor and cognitive 
functions (Hagberg et al., 1983). Several mouse models of RS have been developed, 
recapitulating motor, cognitive, and behavioural features typical for the human syndrome 
(Stearns et al., 2007) and demonstrating a LTP impairment in the hippocampus and the motor 
and sensory cortex (Asaka et al., 2006, Moretti et al., 2006). Also in this case, EE has proved 
beneficial, resulting in a reduction of anxiety-related behaviours, improvement of motor 
coordination and learning, locomotor activity and memory deficits and normalization of LTP 
expression in different models of RS (Kondo et al., 2008, Kerr et al., 2010, Lonetti et al., 
2010).  
Finally, the Ts65Dn mice, the animal model of DS addressed in detail in the first 
chapter, have been exposed to EE. EE resulted in an improvement of spatial cognitive 
abilities in MWM in a sex-specific manner, with EE-female Ts65Dn mice performing better 
than untreated experimental group and EE-male Ts65Dn mice being incapable to learn the 
task (Martinez-Cue et al., 2002). On the contrary, there was no sex difference in rescue of 
hippocampal neurogenesis deficit after enrichment in adult Ts65Dn mice (Chakrabarti et al., 
2011). However, little is known about the effects of EE on synaptic plasticity and 
GABAergic signaling in the brain, indicating that further studies are necessary to better 
understand how increased environmental stimulation may impact disrupted neural 




2.6. Enviromimetics – a novel class of therapeutics 
The impressive results coming from animal studies that illustrate the activation of an array of 
molecular pathways in response to EE encourage the application of these findings to the 
human population (Greenwood, 2007, Greenwood and Parasuraman, 2010). Important 
questions are how the environmental stimulation of animals in a laboratory setting relates to 
the complexity and diversity of human lives and how this therapeutic strategy should be 
translated to clinical trials. Most humans experience high levels of novelty throughout life, 
and there is a notable difference in the quantity and quality of mental stimulation, physical 
activity and social engagement between persons. This implies that it may be not always 
feasible to identify the level of richness experienced by individuals and to optimize their 
living conditions and life style in order to obtain benefits for brain function. Moreover, some 
pathological conditions described previously are characterized by low motivation, already 
compromised neural functions and/or other health problems that may impede active 
involvement of these patients in stimulating programs (McOmish and Hannan, 2007) . Thus, 
it has been proposed that pharmacological targeting of the molecules that mediate the benefits 
of EE, aiming at reproduction or strengthening of its positive effects, may be a good 
alternative strategy to promote brain health and plasticity (McOmish and Hannan, 2007, Pang 
and Hannan, 2013). 
The animal models described above are ideally suited for screening and 
characterization of enviromimetics, a novel class of therapeutics capable of mimicking the 
neural outcomes of EE. Given that EE results in an enhancement of neural plasticity, a 
candidate drug would be expected to induce cellular changes, such as facilitation of synaptic 
plasticity, synaptogenesis or adult neurogenesis, in a manner analogous to environmental 
stimulation (McOmish and Hannan, 2007). One possibility, in line with a classical aetiology-
based therapeutic approach, is to search for the disease specific molecular disruptions and to 
58 
 
target them directly in order to correct the deficit and obtain a clinical improvement. An 
example of this approach may be a drug that mimics or activates neprilysin, an enzyme 
thought to be a limiting step in Aβ degradation (Iwata et al., 2001); neprilysin has been 
shown to be up-regulated in enriched AD mice, in association with reduction of amyloid load 
and plaques (Lazarov et al., 2005). Another appealing possibility is to focus on a 
pharmacological normalization of pathophysiological mechanisms that seem to overlap in a 
wide range of nervous system disorders. An example in this case could be targeting of over-
inhibition in various forms of  DIDs, as there is mounting evidence that these disorders are 
associated with excessive GABAergic transmission (Fernandez and Garner, 2007).     
Plausible pharmaceuticals that would meet the criteria for enviromimetics do not refer 
exclusively to novel compounds, they may also include drugs already in the clinical use. 
Indeed, it has been demonstrated that the molecular pathways involved in the regulation of 
neuronal plasticity in models of learning and memory are also activated by drugs used for the 
treatment of depression and bipolar disorder (Duman et al., 2000).  
 
2.7. Antidepressant fluoxetine as a putative enviromimetic 
The selective serotonine reuptake inhibitor fluoxetine is a commonly prescribed drug for the 
treatment of mood and anxiety disorders. Fluoxetine enhances serotonergic transmission by 
blocking the serotonin transporter (5-HTT) located on plasma membrane of serotonergic 
neurons, leading to increased 5-HT extracellular levels and sustained activation of pre- and 
postsynaptic 5-HT receptors (Tatsumi et al., 1997). 5-HT is produced by serotonergic 
neurons located in the raphe nuclei in the brain stem, which send their diffuse projections 
throughout the whole brain affecting multiple processes such as learning and memory  
(Buhot, 1997, Meneses, 1999, Riedel et al., 1999, Buhot et al., 2000, Schmitt et al., 2000), 
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emotion (Asberg et al., 1976, Meneses and Liy-Salmeron, 2012), feeding (Tecott, 2007), 
sleep (Trivedi et al., 1999, Ivarsson et al., 2005, Silber and Schmitt, 2010), sexual and other 
social behaviours (Ferrari et al., 2005, Chan et al., 2008, Carrillo et al., 2009) and sensory 
perception (Wei et al., 2010).   
Animal studies have shown that fluoxetine treatment enhances neuronal plasticity 
processes in adult brain, such as BDNF signalling and hippocampal neurogenesis (Duman 
and Monteggia, 2006, Martinowich et al., 2007). It has been demonstrated that chronic, but 
not acute, antidepressant administration enhances CREB expression and phosphorylation in 
limbic brain structures, including hippocampus and cerebral cortex (Nibuya et al., 1996, 
Thome et al., 2000) and leads to up-regulation of BDNF (Nibuya et al., 1995, Russo-Neustadt 
et al., 1999). It is believed that an increased CREB and BDNF expression contributes to the 
effects of fluoxetine on neural plasticity, including synaptic remodeling and increased 
neurogenesis in WT animals (Duman, 2002). Moreover, it has been shown that treatment 
with fluoxetine is able to rescue the neurogenesis impairment in the mouse models of HD, 
leading to improvement of cognitive deficit displayed by these animals (Grote et al., 2005).  
The potential of fluoxetine to induce plastic responses in the adult brain has been also  
evaluated in the visual system. Studies performed on adult amblyopic rats have shown that 
chronic fluoxetine administration induces a plastic response in the mature visual cortex that 
closely resemble that observed at the peak of the critical period (Maya Vetencourt et al., 
2008, Castren et al., 2012). Furthermore, fluoxetine treatment during adulthood, in 
combination with the encouragement of the use of the weak eye, fully restored VA of the 
amblyopic eye (Maya Vetencourt et al., 2008, Castren et al., 2012). The enhancement of adult 
plasticity induced by fluoxetine is accompanied by a reduction of GABA-mediated inhibition, 
together with increased BDNF signalling and activation of 5HT1A serotonin receptors (Maya 
Vetencourt et al., 2008, Maya Vetencourt et al., 2011). An independent study based on two-
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photon imaging in vivo reported that pharmacological reduction of intracortical inhibition by 
fluoxetine was able to promote parameters of structural plasticity in the adult brain. In this 
study fluoxetine treatment, in a combination with a brief MD, led to increased dendritic 
branch dynamics of superficial L2/3 interneurons in the adult visual cortex, facilitating in this 
manner circuit specific modification driven by experience (Chen et al., 2011). 
The pharmacological enhancement of neural plasticity elicited by fluoxetine is not 
limited to the hippocampus and the visual cortex. A recent study performed on mice rendered 
anxious by fear conditioning and afterwards treated with a protocol of fear extinction and 
fluoxetine explains why an optimal therapeutic outcome is achieved only when the 
pharmacological and cognitive behavioural approach are combined. Specifically, it has been 
reported that chronic fluoxetine treatment reactivates a juvenile-like plastic state in the 
basolateral amygdala of anxious mice, enabling a permissive environment for re-adaptation 
of affected neural circuits driven by instructive stimuli deriving from psychotherapy 
(Karpova et al., 2011). In a similar manner, pharmacological reactivation of juvenile-like 
plasticity induced by SSRIs may be responsible for facilitation of the rehabilitation and 
functional recovery after an ischemic brain injury in rodents (Acler et al., 2009, Jorge et al., 
2010, Chollet et al., 2011). Finally, very recent data suggest that chronic fluoxetine 
administration also promotes the restoration of motor function after a spinal cord lesion (Scali 
et al., 2013).  
Based on the capability to enhance neural plasticity, fluoxetine has started to emerge 
as a potential pharmacological treatment also for DS. It has been shown that four weeks of 
adult-onset fluoxetine treatment are sufficient to normalize deficient adult hippocampal 
neurogenesis in Ts65Dn mice, although it was not tested whether this increase of 
neurogenesis was accompanied by a recovery of hippocampus-dependent cognitive deficits 
(Clark et al., 2006). A more recent study has reported that fluoxetine administration for 13 
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days to neonate Ts65Dn mice fully rescues postnatal neurogenesis in DG and subventricular 
zone (SVZ), restores expression of BDNF and 5-HT1A receptors and improves contextual 
fear conditioning impairment in juvenile trisomic mice (Bianchi et al., 2010b). Beside the 
positive effects on neurogenesis, early postnatal fluoxetine treatment also favours dendritic 
arborisation in young Ts65Dn mice (Guidi et al., 2013). Given that DS is characterized by 
developmental deficits in dendritic maturation, it is expected that restoration of this process 
by early-onset fluoxetine treatment may lead to optimization of synaptic connectivity and 
neural function (Bartesaghi et al., 2011).  
All together these data indicate that an enhancement of serotonergic transmission 
elicited by fluoxetine may favour plasticity of multiple neural networks involved in 
cognition, sensory perception, emotions and motor performance. Thus, fluoxetine treatment 
emerges as a promising therapeutic opportunity for a wide spectrum of CNS pathologies. The 
ongoing clinical trials will reveal whether encouraging findings from animal studies can be 














AIM OF THE THESIS AND EXPERIMENTAL DESIGN 
 
DS is a genetic neurodevelopmental disorder characterized by a set of clinical features with 
CNS abnormalities and ID as the most limiting aspects of the pathology. While improved 
medical and social care in the last two decades resulted in a significant improvement of 
physical health and life quality in DS patients, there is still need for interventions aiming at 
the prevention and/or amelioration of neurocognitive dysfunction associated with DS.  
In the first part of my Thesis, I addressed the possibility to ameliorate DS-related 
neurocognitive phenotypes in adulthood. In Ts65Dn mice abnormally high levels of 
inhibitory synaptic transmission have been associated with deficient hippocampal synaptic 
plasticity (Kleschevnikov, 2004), an important cellular mechanism for learning and memory 
formation. A ground-breaking study demonstrated that chronic treatments with GABAA 
receptor antagonists reversed synaptic plasticity impairments and cognitive deficits displayed 
by adult Ts65Dn mice (Fernandez et al., 2007), indicating that lowering of inhibitory tone 
may be a promising therapeutic strategy. However, since persons with DS are more 
susceptible to convulsions (Menendez, 2005), concerns can be raised on the clinical 
application of GABAA receptor antagonists, which are characterized by a narrow therapeutic 
window and pro-convulsive action. Thus, I  investigated the possibility to lower GABAergic 
transmission and promote plasticity processes in adult Ts65Dn mice with treatments more 
eligible for human application, such as EE, a behavioral paradigm of increased sensory-motor 
stimulation, and pharmacotherapy with fluoxetine, a commonly prescribed antidepressant for 
the treatment of mood and anxiety disorders. Using the visual system as a model for the study 
of experience-dependent plasticity, it has been demonstrated that these two therapeutic 
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strategies can be efficiently employed to reduce cortical inhibition (Sale et al., 2007b, Maya 
Vetencourt et al., 2008, Baroncelli et al., 2010b), enhancing neuronal plasticity in the adult 
brain.  
First, I studied the effects of EE on adult Ts65Dn mice of both sexes. It has been 
already reported that exposing Ts65Dn mice to EE in large groups (8-10 mice per cage) 
improves their spatial learning abilities in a sex-specific manner, with rescue of performance 
in females and deterioration in males (Martinez-Cue et al., 2002). As there is a tendency 
toward social subordination in Ts65Dn male mice (Martinez-Cue et al., 2006), disruption of 
spatial learning and memory in trisomic males has been attributed to elevated level of 
perceived stress due to excessive social stimulation as a component of EE (Martinez-Cue et 
al., 2005). Thus, to optimize the social configuration of housing environment for male mice, I 
used a protocol of EE in which only two-three Ts65Dn males from the same litter were reared 
together; trisomic females were housed in group of 6-8 mice per cage. After 6 weeks of 
enrichment, I evaluated spatial learning and memory, synaptic plasticity, visual functions and 
GABAergic transmission in adult Ts65Dn mice. 
For assessment of the behavioral response to EE, I used the MWM test, a 
hippocampus-related task that measures spatial learning and memory, in which Ts65Dn mice 
have impaired performance (Escorihuela et al., 1995, Reeves et al., 1995, Demas et al., 1996, 
Holtzman et al., 1996). Since poor performance in MWM displayed by Ts65Dn mice has 
been associated with deficient synaptic plasticity (Siarey et al., 1997, Siarey et al., 1999, 
Kleschevnikov, 2004, Fernandez et al., 2007), I evaluated, for the first time in this model, the 
effects of EE on hippocampal LTP. Specifically, I studied LTP in response to high frequency 
stimulation in DG, a hippocampal region severely affected by excessive levels of inhibition in 
Ts65Dn mice (Belichenko et al., 2004, Fernandez et al., 2007, Kleschevnikov et al., 2012). 
Since it has been recently reported that Ts65Dn mice have visual deficits similar to 
64 
 
those seen in DS patients (Scott-McKean et al., 2010), I also investigated the therapeutic 
potential of EE to rescue these visual impairments. I used in vivo electrophysiological 
recordings of VEPs from V1 to assess the effects of EE on the following visual functions: 
VA, binocularity (by calculating the contralateral-to-ipsilateral VEP ratio) and VEP latencies. 
 Finally, I used a biochemical model of neurotransmitter release from synaptosomes, 
preparations of synaptic terminals that remain intact after homogenization of nerve tissue, to 
analyze the properties of inhibitory transmission in Ts65Dn mice after exposure to EE. I 
measured the depolarization-evoked release of GABA from synaptosomes in the 
hippocampus and in V1. It is important to note that enhanced levels of inhibition in Ts65Dn 
mice have been mainly documented in the hippocampus; thus I provided the first evidence 
regarding GABAergic transmission in the visual cortex of trisomic mice. 
Since a recently published paper reported severe side effects of a high-dose fluoxetine 
administration (80 mg/kg/day) in Ts65Dn mice (Heinen et al., 2012), I performed a pilot 
experiment aimed at assessing the occurrence of fluoxetine side effects in animals treated 
with 3 different dosage schemes, that is 40, 20 and 10 mg/kg/day. This study demonstrated 
that 10 mg/kg/day is a safe dose in Ts65Dn mice, in line with the dosage used in previous 
studies that reported beneficial effects of fluoxetine treatment on neurogenesis deficits (Clark 
et al., 2006, Bianchi et al., 2010b). Then, I used this dosage to assess the effects of chronic 
fluoxetine administration (8 weeks) on behavior, synaptic plasticity and inhibitory 
transmission in Ts65Dn and WT mice. 
Initially, I investigated the impact of adult-onset fluoxetine treatment on spatial 
learning and memory in MWM. Then, I also used the novelty place recognition (NPR) test, a 
hippocampal-based recognition memory test,  in which the performance of Ts65Dn mice is 
also impaired (Kleschevnikov et al., 2012). 
 Afterwards, I examined whether fluoxetine treatment was able to restore deficient 
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hippocampal LTP. Specifically, I studied LTP at the CA3-CA1 hippocampal synapses, 
another hippocampal region with aberrant synaptic plasticity in Ts65Dn mice (Siarey et al., 
1997, Kleschevnikov, 2004, Costa and Grybko, 2005), in  response to theta burst stimulation. 
Finally, I measured depolarization-evoked GABA release from hippocampal 
synaptosomes,  in order to evaluate the effects of a chronic fluoxetine administration on 
inhibitory transmission strength in Ts65Dn mice.  
In the second part of my Thesis, I studied brain development in Ts65Dn mice. I 
focused on the visual system development, as it is currently not known if the deficits of visual 
functions displayed by adult Ts65Dn mice originate from disrupted developmental 
mechanisms or rather represent a sign of early-onset neurodegeneration. Since it has been 
shown that rearing WT animals from birth in EE accelerates visual system development 
(Cancedda et al., 2004, Sale et al., 2004), I investigated whether a complex sensory-motor 
stimulation provided by preweaning exposure to EE affects the maturation of visual system in 
Ts65Dn offspring.  
As an integral part of the developmental study, I analyzed postpartum maternal care in 
Ts65Dn mice. Since it has been demonstrated in WT animals that EE promotes maternal care 
(Sale et al., 2004), I performed a set of behavioral observations in Ts65Dn females during the 
first eleven postpartum days, in both enriched and standard conditions. The EE procedure 
was started since pregnancy, thus avoiding possible stress that could have been experienced 
by Ts65Dn mothers if housing conditions were changed immediately before delivery. I 
weaned and sexed pups at P28 and reared them in EE until the end of experimentation. Then I 
monitored the timing of eye-opening and the maturation of VA at three different time points, 





 MATERIALS AND METHODS 
 
4.1. Animals 
The transgenic line Ts65Dn was used in this study. Ts65Dn mice carry segmental trisomy in 
a form of Robertsonian translocation of Mmu16 to Mmu17 (17
16
). Segmental trisomy 
provokes male sterility, therefore female carriers of the 17
16
 chromosome (B6EiC3H – 
a/ATs65Dn) are used to generate trisomic offspring by intercross with (C57BL/6JEi x 
C3H/HeJ) F1 hybrid male mice. Ts65Dn mice are thus maintained on the B6/C3H 
background (Davisson et al., 1993). The marker chromosome 17
16
 is inherited at expected 
Mendelian frequency, but, due to the perinatal loss, only 20-40% of the offspring of Ts65Dn 
mothers are trisomic at weaning. Moreover, the proportion of trisomic mice per litter 
decreases with the age of the Ts65Dn mother (Roper, 2005). Diploid (WT) mice of the same 
litter were used as a control experimental group.  
The low reproductive outcome of Ts65Dn mice is further compromised by the 
recessive retinal degeneration (rd) mutation that segregates in C3H/HeJ background and 
leads to blindness by ~1 month of age in about 25% of newborns from Ts65Dn mothers. This 
limits the use of rd positive homozygotes in behavioral experiments (Reeves et al., 1995, Das 
and Reeves, 2011). This problem has been recently overwhelmed through the breeding of 
Ts65Dn extra chromosome across many generations into a closely related genetic 
background free of rd mutation. Analysis of the effects of this new genetic background on 
mice performance revealed no significant differences in behavioral phenotype respect to the 
original Ts65Dn model (Costa et al., 2010). 
 In the present study the effects of EE in adulthood were investigated on Ts65Dn mice 
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maintained on background with segregating rd mutation, while the impact of EE on CNS 
development and the response of adult mice to pharmacotherapy with fluoxetine were 
evaluated in Ts65Dn strain free of rd mutation. Ts65Dn mating couples were originally 
obtained from The Jackson Laboratory (Bar Harbor, Maine, USA) and colonies of both type 
of Ts65Dn strain, with- and free of rd mutation, were established. The progeny of colonies 
was genotyped by a quantitative PCR (qPCR) protocol developed by The Jackson Laboratory 
(http://www.jax.org/cyto/quanpcr.html). For the pharmacological part of the study adult 
Ts65Dn and WT mice were acquired directly from The Jackson Laboratory. All mice arriving 
from The Jackson Laboratory were acclimated to the controlled housing conditions for at 
least one week before inclusion in the study. 
 
4.2. DNA extraction  
Genomic DNA was extracted according to the protocol developed by The Jackson 
Laboratory. Tail tips (3 mm) were collected and subsequently digested with 300 ul of 50 mM 
NaOH for 1 h at 98°C, with a brief resuspension after 30min. After incubation, DNA was 
dissolved in 30 ul of 1 M Tris (pH8), resuspended and centrifuged for 6 min at 14000 rpm. 
The supernatant was used for qPCR genotyping and PCR screening for retinal degeneration.   
  
4.3. Genotyping 
All mice obtained from internal colonies were genotyped using real-time qPCR with TaqMan 
probes (Applied Biosystems) specific for the following genes: App, apolipoprotein B (ApoB) 
and myxovirus resistance 1 (Mx1). Genes for App and Mx1 were used as the target (marker) 
genes, whereas the ApoB gene was used as internal control. The rationale is that App and Mx1 
are located in the chromosome segment triplicated in Ts65Dn, whereas ApoB is mapped on 
Mmu12. Thus, Ts65Dn samples have three copies of App and Mx1, whereas WT samples 
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have only two copies. Both Ts65Dn and WT animals have two copies of ApoB. The extra 
copy of App or Mx1 in trisomic samples is detected by qPCR. The reaction was performed on 
StepOne™ instrument at 50°C for 2 min, 95°C for 10 min, followed by 40 cycles of 95°C for 
15s and 60°C for 1 min. After amplification, the average change in cycle threshold (CT) of 
the target gene App/Mx1 from that of ApoB in sample animals with respect to controls was 
calculated: 
 CT = (CTApp/Mx1 – CTApoB)trisomic – (CTApp/Mx1 – CTApoB)euploid) 
The CT value for App or Mx1 in trisomic samples is <  – 0.3. The sequences of 
primers and probes were as follows: 
ApoB   forward primer         5’-CACGTGGGCTCCAGCATT-3’ 
            reverse primer          5’-TCACCAGTCATTTCTGCCTTTG-3’  
            probe                        5’-CCAATGGTCGGGCACT-3’ 
App      forward primer         5’-TGCTGAAGATGTGGGTTCGA-3’;  
             reverse primer          5’-GACAATCACGGTTGCTATGACAA-3’;  
             probe                        5’-CCATCATCGGACTCAT-3’; 
Mx1      forward primer         5’-TCTCCGATTAACCAGGCTAGCTAT-3’ 
             reverse primer          5’-GACATAAGGTTAGCAGCTAAAGGATCA-3’ 
             probe                        5’-TGGCTTTCCTGGTCGC-3’ 
 
4.4. Screening for retinal degeneration  
All genotyped mice of Ts65Dn strain with rd mutation were screened for the presence of 
retinal degeneration using a qualitative PCR protocol. Retinal degeneration in the Ts65Dn 
mouse is inherited as an autosomal recessive trait and is caused by a mutation in the rd gene 
mapped on Mmu5 encoding the β subunit of cGMP phosphodiesterase (β-PDE) expressed in 
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rod photoreceptors (Bowes et al., 1993). PCR screening is based on a difference between 
length of normal and aberrant rd genes, as the wt gene is 260 pb long, while the mutated gene 
is 560 pb long. The gene of interest was amplified from genomic DNA by Taq polymerase 
and gene specific forward and reverse primers (Sigma). After amplification performed in a 
thermal cycler at 94°C for 5 min, followed by 35 cycles of 94°C for 30 s, 65°C for 30 s and 
72°C for 1min 30 s, PCR products were identified by their size using agarose gel 
electrophoresis. The rd
-/-
 samples displayed only low weight band relating to wt rd gene, the 
rd
+/+ 
samples displayed only high weight band relating to mutant rd gene, while rd
+/- 
samples 
displayed both low weight and high weight band. Homozygotes rd
+/+ 
were excluded from the 
experiments. 
 
4.5. Rearing environments 
EE, a complex rearing environment composed of motor, sensory, cognitive and social 
stimulation, consisted of a large Plexiglas cage (44x62x28 cm) with a wire mesh lid 
containing standard laboratory bedding, several food hoppers, running wheels, and various 
objects of different shape (e.g. tunnels, shelters, stairs) and material (e.g. wood, plastic, 
glass). Once per week the position of food hoppers were changed and the objects were 
completely replaced with others. Standard conditions (SC) consisted of a standard Plexiglas 
laboratory cage (26x42x18 cm) with a wire mesh lid containing only standard laboratory 
bedding. In both experimental conditions mice had ad libitum access to a standard laboratory 
chow diet and tap water throughout the study. All animals were maintained at 12h/12h light-
dark cycle with lights on at 6 a.m.. 
Rearing conditions for the study of the effects of EE on Ts65Dn mice in adulthood   
WT mice (> P60) were maintained in SC cages housing a maximum of 3 females or brother 
males. Age-matched Ts65Dn mice were reared for 6 weeks in either EE or in SC cages. 
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Every EE cage housed at least six females; since it is known that Ts65Dn males have a 
tendency toward social subordination and that an excess of social stimulation can disturb 
their behavioral and learning skills (Martinez-Cue et al., 2005), I used a protocol of EE in 
which only 2-3 Ts65Dn males from the same litter were reared together.  
Rearing conditions for the study of the effects of EE on the development of Ts65Dn mice   
Female Ts65Dn mice were assigned to either enriched (3 adult females or 2 adult females and 
1 helper adult female or 1 adult female and 2 adult females) or to standard cages (1 female). 
One male was added to every mating cage. For all breeding, males were removed from the 
mating cage at least 7 days before delivery and mothers and offspring left undisturbed until 
P11, at which time an evaluation of eye opening was started. Pups were weaned and sexed at 
P28. Rearing conditions (SC and EE) after weaning corresponded to those at the birth.  
Rearing conditions for the pharmacological study   
Adult WT and Ts65Dn mice were maintained in SC cages. Males were singly housed, while 
females were reared in small groups composed of a maximum of 4 animals per cage.  
 
4.6. Pharmacological treatment 
Age-matched Ts65Dn and WT mice of both genders were either systemically treated with 
fluoxetine (Fluoxetine-hydrochloride, Galeno, Prato-Italy) dissolved in tap water for 8 weeks, 
or subjected to a normal water drinking regimen. Solutions were prepared fresh twice a week.  
As a preliminary study aimed at optimizing fluoxetine dose, I evaluated three decreasing drug 
concentrations within the range of fluoxetine dosing schemes generally used in mice and rats 
(Rantamaki et al., 2007, Maya Vetencourt et al., 2008, Karpova et al., 2011), that is 40, 20 
and 10 mg/kg/day (fluoxetine was dissolved in tap water at the following, respective, 
concentrations: of 0.10, 0.05 and 0.025 mg/ml), and I monitored, for the entire length of the 
treatment, animal survival and seizure susceptibility through behavioral observations (two 
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weekly observation sessions of 60 min each for the 8 weeks of treatment). I analyzed the 
following 8 different experimental groups (numbers after fluox indicate the corresponding 
drug doses for each group): Ts65Dn-fluox40; Ts65Dn-fluox20; Ts65Dn-fluox10; Ts65Dn-
water; WT-fluox40; WT-fluox20; WT-fluox10 and WT-water. 
 To control drug assumption, I performed a pilot experiment in which I quantified the 
consumption of drinking water and fluoxetine solution (0.025 mg/ml) in a cohort of adult 
Ts65Dn animals, for five consecutive days. I found that the amounts of consumed water and 
fluoxetine solution were not statistically different among different individuals (Ts65Dn-
water, n = 4, I day: 10.8 ± 0.9 ml, II day: 10.3 ± 0.9 ml, III day 11.8 ± 0.3 ml, IV: 9.5 ± 1.2 
ml, V: 11.3 ± 0.6 ml; Ts65Dn-fluox, n = 4, I day: 10.8 ± 1.4 ml, II day: 9.0 ± 2.5 ml, III day 
10.0 ± 1.6 ml, IV: 9.3 ± 1.1 ml, V: 10.3 ± 0.6 ml) (Two-way RM ANOVA, p = 0.537). 
Moreover, also the individual weights of mice did not significantly differ among each others 
(Ts65Dn-water: 22.50 ± 1.02; Ts65Dn-fluoxetine: 23.01 ± 0.39; t-test, p = 0.653). Thus, 
delivering fluoxetine in the drinking water did not result in substantial differences in the 
reliable average doses of the compound taken in by different individuals. 
 
4.7. Maternal care observations 
Postpartum maternal and helper female behaviors were observed inside mating EE and SC 
cages, applying an observational protocol modified from Cancedda et al. (2004) and Sale et 
al. (2004). Behavioral observations started at P1 and were conducted every second day until 
P11. Maternal/helper female behaviors were scored during 4 daily observation sessions of 45 
min. The observation sessions occurred at  10 a.m., 1 p.m., 4 p.m. and 7 p.m.; the last 
sessions was during dark phase of the daily cycle and was performed under dim red light. 
During each session the behavior of each female was scored every 3 min, recording whether 
the target behavior was present or not.  
72 
 
Scored behaviors (not mutually exclusive):  
Mother/helper female in the nest (passive stimulation) –  the mother and/or the 
helper is touching of at least one pup with a part of her body other then the tail. 
 Stepping – the adult female steps gently over the pups’ body and stimulates them. 
Licking – general licking of any part of a pup body.  
Nest building – activities aimed at nest construction and reconsolidation.  
Arched back nursing – the mother is immobile and in a characteristic high upright 
dorsal arched posture with all or most pups attached to the nipples; this position provides the 
most effective  nourishment for the pups. 
Data are reported as the percentage of observations in which pups received the target 
behavior (Liu et al., 2000).  
 
4.8. Eye-opening observation 
 
Starting from P11, pups were daily inspected for eye-opening at 4 p.m. Eye-opening was 
defined as the initial break in the membrane sealing the lids of both eyes. 
 
4.9. Morris water maze 
 
Mice were trained for 2 trials per day and for a total of 10 days in a circular water tank, made 
from grey polypropylene (diameter, 100 cm; height, 40 cm), filled to a depth of 25 cm with 
water (23°C) rendered opaque by the addition of a small amount of atoxic white paint. Four 
positions around the edge of the tank were arbitrarily designated North (N), South (S), East 
(E), and West (W), which provided four alternative start positions and also defined the 
division of the tank into 4 quadrants: NE, SE, SW, and NW. To avoid possible confounding 
effects due to reduced visual acuity in Ts65Dn mice, the tank was surrounded by a set of 
73 
 
extra-maze cues in the visual discrimination range detectable by all experimental groups. A 
circular clear Perspex escape platform (diameter, 10 cm; height, 2 cm) was submerged 0.5 cm 
below the water surface and placed at the midpoint of one of the four quadrants. The hidden 
platform remained in the same quadrant during training, while the start positions (N, S, E, or 
W) were randomized across trials. Mice were allowed to locate the escape platform up to 60 
s, and their escape latency was automatically recorded by the Noldus Ethovision system. In 
the last trial of the last training day, mice received a single probe trial, during which the 
escape platform was removed from the tank and the swimming paths were recorded over 60 s 
while mice searched for the missing platform. The swimming paths were recorded and 
analyzed with the Noldus Ethovision system. 
 
4.10. Novel place recognition test 
 
Performance in the NPR test was tested using a modified protocol from Kleschevnikov et al. 
(2012). Mice were habituated to a Plexiglas rectangular chamber (30 x 22 x 20 cm) for 10 
min on 2 consecutive days under dim ambient light conditions. The activity of mice was 
recorded with a video camera. Test had 2 phases: acquisition and testing. For acquisition, 2 
identical objects were placed in corners of the chamber, 2 – 3 cm from the walls. A mouse 
was placed at the midpoint between the objects. After allowing 10 min to explore the objects, 
the mouse was returned to the colony. For the test phase, one of the objects was moved in a 
new location at the center of the chamber, while the other object remained at its former 
spatial location. Testing was performed 10 min after the acquisition, the mouse was again 
placed in the chamber and allowed to explore the objects for 3 min. The amount of time spent 
exploring each object (nose sniffing and head orientation within < 1 cm) was recorded.  
Data are reported as the discrimination index. Discrimination index was computed as: 
                  Discrimination index (%) = T new * 100/(T new + T old) 
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T new is the time spent exploring the object with a new position, and T old is the time spent 
exploring the object with the unchanged position.  
 
4.11. In vitro electrophysiology: LTP recordings 
The brain was rapidly removed and immersed in ice-cold cutting artificial cerebrospinal fluid 
(ACSF) solution containing (in mM): 130 NaCl, 3.1 KCl, 1.0 K2HPO4, 4.0 NaHCO3, 5.0 
dextrose, 2.0 MgCl2, 1.0 CaCl2, 10 HEPES, 1.0 ascorbic acid, 0.5 myo-Inositol, 2.0 pyruvic 
acid, 0.01 glycine and 1.0 kynurenate, pH 7.35. Both hippocampi were extracted and cut with 
a tissue chopper into 400µm thick slices. Hippocampal slices were allowed to recover in 
oxygenated cutting ACSF free of kynurenate at room temperature for at least 2 h before 
recordings.  
A slice was transferred into the recording chamber and perfused at a constant rate of 4 
ml/min with 30°C oxygenated recording ACSF solution. The recording ACSF solution was 
composed as the cutting ACSF solution with the following differences (in mM): 1.0 MgCl2, 
2.0 CaCl2, and no kynurenate. Electrical stimulation (100 μsec duration) was delivered with a 
bipolar concentric stimulating electrode (FHC, St. Bowdoinham, ME). The stimulating 
electrode was inserted into the middle molecular layer of the DG (stimulation of the perforant 
path projections) or into CA3 (stimulation of  Schaffer collateral  fibers); dendritic field 
excitatory post-synaptic potentials (fEPSPs) were recorded by a micropipette (1–3M) filled 
with the recording ACSF solution and positioned into the granule cell layer of the DG upper 
blade or into CA1 stratum radiatum, respectively. An input/output curve was generated by 
delivering stimuli of increasingly higher intensities and recording the corresponding fEPSP 
amplitudes until a plateau was reached. Baseline responses were obtained every 30 s with a 
stimulation intensity that yielded responses of 50-60% of saturation.  
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After achievement of a 15 min stable baseline (field potential amplitude within 15% 
of change and with no evident increasing or decreasing trends), LTP was induced as follows:  
DG: high frequency stimulation (HFS) (4 trains at 100 Hz of 0.5 s duration; inter-train 
interval – 30 s);  
CA3: theta burst stimulation (TBS) (4 trains of 10 bursts delivered at 5 Hz; burst 
composition – 4 stimuli at 100 Hz of 1 ms duration; inter-train interval – 15 s). 
After delivery of high frequency/theta burs stimulus, the fEPSP amplitudes were recorded for 
following 60 min. Field recordings were filtered and digitized with an A/D board (National 
Instruments) driven by a custom acquisition software. LTP graphs were generated by 
averaging the amplitude of the fEPSPs in 1 min bins, and expressing data as percentage of the 
averaged baseline collected before LTP induction. Field potential potentiation was evaluated 
by comparing the last 20 minutes post-theta to baseline.  
 
4.12. In vivo electrophysiology: assessment of visual acuity and binocularity 
Mice were anesthetized by i.p. injection with Zoletil-100 (40 mg/kg, Virbac), and Xilor (10 
mg/kg, Sigma) and placed in a stereotaxic frame. Additional doses of anesthetic were used to 
keep the anesthesia level stable throughout the experiment. Body temperature was 
continuously monitored and maintained at ~37°C by a thermostated electric blanket. A hole 
was drilled in the skull, corresponding to the binocular portion of the primary visual cortex 
(binocular area Oc1B). After exposure of the brain surface, a micropipette filled with NaCl 
(3M) was inserted into the cortex 2.7-3.5 mm from λ (intersection between sagittal and 
lambdoid sutures). Both eyes were fixed and kept open by means of adjustable metal rings 
surrounding the external portion of the eye bulb. The eyes were frequently inspected and 
rinsed with physiological solution to prevent the formation of cataracts.  
VA was measured using VEPs. To record VEPs, the electrode was advanced at a 
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depth of 100 or 400 µm within the cortex. At these depths, VEPs had their maximal 
amplitude. Signals were band-pass-filtered (0.1-100 Hz), amplified and fed to a computer for 
analysis. At least 50 events were averaged in synchrony with the stimulus contrast reversal. 
Transient VEPs in response to abrupt contrast reversal (1 Hz) were evaluated in the time 
domain by measuring the peak-to-baseline amplitude and peak latency of the major positive 
(at 100 µm depth) or negative (at 400 µm depth) component. Visual stimuli were horizontal 
sinusoidal gratings of different spatial frequencies, generated by a VSG2/2 card running 
custom software and presented on a monitor (20 x 22 cm; luminance 15 cd/m
2
) positioned 20 
cm from the mouse eyes. VA was obtained by extrapolation to zero amplitude of the linear 
regression through the data points in a curve where VEP amplitude is plotted against log 
spatial frequency. 
Binocularity was assessed calculating the contralateral to ipsilateral (C/I) VEP ratio at 
0.05 c/deg, i.e. the ratio of VEP amplitudes recorded by stimulating the contralateral and 
ipsilateral eye with respect to the brain side where recording is performed. For each animal, 
at least 12 independent C/I VEP ratio values were calculated and averaged together from 3 
well-spaced traces along the medio-lateral and antero-posterior axes of the primary visual 
cortex. Care was taken to equally sample VEPs across the two cortical depths so that all 
layers contributed to the analysis. 
 
4.13. Analysis of GABA release in hippocampal and visual cortex 
synaptosomes 
Animals were sacrificed and the brain regions corresponding to the primary visual cortex and 
to the hippocampus were removed. Synaptosomes were prepared essentially as previously 
described (Stigliani et al., 2006). The tissue was homogenized at 4°C, utilizing a 
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homogenizer Teflon/glass (clearance 0.25 mm), in 10 volumes of sucrose 0.32M, buffered 
with Tris-HCl at pH 7.4. The homogenized tissue was centrifuged (5 min, 1000 x g a 4°C) in 
order to remove all nuclei and cellular fragments. Then, the supernatant was gently stratified 
on a discontinuous Percoll gradient (2, 6, 10, 20% v/v in tris HCl/sucrose) and again 
centrifuged (33500 x g per 5 min a 4°C). After centrifugation, the stratified fraction of 
synaptosomes, leaning between 10% and 20% Percoll, was collected, washed by 
centrifugation (20200 x g per 15 min a 4°C) and then resuspended in a physiologic medium, 
containing: NaCl 140mM; KCl 3mM; MgCl2 1.2mM; CaCl2 1.2mM; NaH2PO4 1.2mM; 
HEPES 10mM; glucose 10mM; pH 7.4.  
Synaptosomes were incubated at 37°C for 15 min with the radioactive tracers [
3
H]D-
GABA, at a final concentration of 0.05μM (plus 50 µM of the GABA transaminase inhibitor 
amino-oxyacetic acid). Aliquots of the synaptosomal suspensions were layered on 
microporous filters at the bottom of a set of parallel superfusion chambers (Superfusion 
System, Ugo Basile, Comerio, Varese, Italy) maintained at 37°C. Superfusion was started at a 
rate of 0.5 ml/min with standard medium supplemented with 50 µM amino-oxyacetic acid. 
After 36 min of superfusion, to equilibrate the system, samples were collected according to 
the following scheme: one sample collected for 3-min (t = 36-39 min; basal outflow); one 
sample collected for 6-min (t = 39-45 min; stimulus-evoked release); one sample collected 
for 3-min (t = 45-48 min; basal outflow after stimulus-evoked release). A 90-s period of 
stimulation was applied at t = 39 min, after the first sample has been collected. Stimulation of 
synaptosomes was performed with 15 mM KCl, substituting for equimolar concentration of 
NaCl. Radioactivity was determined in each sample collected and superfused filters by liquid 
scintillation counting. Tritium released in each sample was calculated as percentage of the 
total synaptosomal tritium content at the beginning of the respective sample collection 
(fractional rate x 100). The stimulus-evoked overflow was estimated by subtracting 
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transmitter content of the two 3-min samples (basal outflow) from release evoked in the 6-
min sample collected during and after the depolarization pulse (stimulus evoked release).  
 
4.14. Statistics 
All statistical analysis was done using SigmaStat Software. Differences between two groups 
were assessed with a two-tailed t test. One-way ANOVA, Two way ANOVA and Two way 
RM ANOVA, followed by multiple comparison procedures Holm–Sidak or Tukey test, were 












CHAPTER 5  
RESULTS 
 
5.1. Effects of adult-onset environmental enrichment and fluoxetine 
treatment on Down syndrome related phenotypes displayed by Ts65Dn 
mice 
In the first part of the presented work I investigated the impact of adult-onset EE and 
fluoxetine administration, two therapeutic strategies shown to be efficacious in treatment of 
neurodevelopmental disorders in adulthood (Castren et al., 2012), on DS-related phenotypes 
displayed by Ts65Dn mice. My results suggest that these two treatments can be successfully 
employed to favour recovery from cognitive impairments and synaptic plasticity failure in 
adult Ts65Dn mice, with EE being effective also in counteracting the visual deficits observed 
in adult trisomic mice. I also report that levels of GABA release are markedly increased in 
the hippocampus and in the visual cortex of Ts65Dn mice compared to WT animals, and that 
exposure to both EE and fluoxetine reduces the inhibitory transmission, normalizing GABA 
release in the synaptosomes of trisomic mice. 
 
5.1.1. Environmental enrichment promotes spatial  learning  and  memory  in  
Ts65Dn mice  
I initially assessed spatial memory abilities in MWM task, a cognitive paradigm in which 
Ts65Dn mice are known to be severely impaired (Escorihuela et al., 1995, Stasko and Costa, 
2004, Fernandez et al., 2007). The latency to locate the submerged platform on the ninth day 
of training was longer in Ts65Dn mice reared in standard environmental conditions (Ts65Dn-
SC, 33.02 ± 8.24 s,  n = 8) compared  to both WT (WT, 14.52 ± 3.34 s, n = 9) and Ts65Dn 
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enriched mice (Ts65Dn-EE, 15.61 ± 2.53, n = 5), while these two latter groups did not differ  


















Figure 1. Environmental enrichment promotes spatial learning in Ts65Dn mice. (A) Learning curves for WT (orange), 
Ts65Dn-SC (violet) and Ts65Dn-EE (yellow). (B) The histogram shows latency to locate the submerged platform on the last 
day of training for the three groups. One Way ANOVA followed by a multiple comparison procedure (Holm-Sidak method) 
showed a statistical difference between WT and Ts65Dn-SC mice and Ts65Dn-SC and Ts65Dn-EE (p < 0.05), but not 
between WT and Ts65Dn-EE mice (p = 0.885). *, statistical significance; error bars, s.e.m.     
To assess the strength of spatial learning, I performed on the last trial of the last 
(tenth) training day a probe trial in which the hidden platform was removed and the amount 
of time spent in the former region of platform was measured. The probe test confirmed the  
spatial memory impairment of Ts65Dn mice: WT mice spent significantly longer time in the 
quadrant where the platform was located during the days of training; in contrast, Ts65Dn-SC 
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mice showed no preference for the target quadrant, indicating that they did not remember the 
location of the hidden platform.  Also in this case, EE was able to completely counteract the 
cognitive deficit displayed by Ts65Dn mice (Figure 2). 
 
Figure 2. Environmental enrichment promotes spatial memory in Ts65Dn mice. Probe trial for WT (orange), Ts65Dn-
SC (violet) and Ts65Dn-EE (yellow) mice. Two Way RM ANOVA revealed a statistically significant interaction between 
the genotype group and the pool quadrant (p < 0.001). A Holm-Sidak multiple comparison procedure revealed that while 
Ts65Dn-SC did not show any preference for the target (NW) quadrant, both WT and Ts65Dn-EE mice spent significantly 
more time in the NW quadrant than in the other quadrants. Moreover, the time spent in the target quadrant was shorter in 
Ts65Dn-SC mice than in the other two groups, which instead did not differ between each other (p = 0.1). *, statistical 
significance; error bars, s.e.m.   
 
5.1.2. Recovery of LTP at medial perforant path–granule cell synapses in 
Ts65Dn mice reared in environmental enrichment 
Since the spatial memory impairment displayed by Ts65Dn mice has been repeatedly related 
to synaptic plasticity deficits in the hippocampus (Siarey et al., 1997, Siarey et al., 1999, 
Kleschevnikov, 2004, Fernandez et al., 2007), I studied LTP in the DG in response to HFS of 
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the perforant path, the circuitry most severely affected by excessive levels of inhibition in the 
Ts65Dn mouse brain (Belichenko et al., 2004, Fernandez et al., 2007, Kleschevnikov et al., 
2012). While I found a strong potentiation of the response after HFS in the DG of WT mice 
(132.04 ± 7.13%, n = 12 slices and 8 animals), no potentiation of field EPSPs with respect to 
baseline was recorded in Ts65Dn-SC mice (105.38 ± 5.85%, n = 10 slices and 5 animals). In 
contrast, a robust rescue of LTP was evident in Ts65Dn-EE mice (124.5 ± 7.67 %, n = 13 
slices and 7 animals) (Figure 3). These results demonstrate for the first time that EE in adult 
Ts65Dn mice is able to restore long-term synaptic plasticity in a neural circuit critically 
involved in spatial learning and memory. 
Figure 3. Recovery of LTP at medial perforant path–granule cell synapses in Ts65Dn mice reared in environmental 
enrichment. Averaged data for LTP induced in WT (orange circles), Ts65Dn-SC (violet circles) and Ts65Dn-EE (yellow 
circles) mice. Slices from WT and Ts65Dn-EE mice showed potentiation of the response after high frequency stimulation 
HFS (Two Way RM ANOVA, baseline vs. the last 20 min post-HFS, p < 0.001), while slices from Ts65Dn-SC did not show 
potentiation (Two Way RM ANOVA, baseline vs. the last 20 min post-HFS, p = 1). A multiple comparison procedure 
(Holm-Sidak method) showed a statistical difference in LTP levels between WT and Ts65Dn-SC mice, between Ts65Dn-SC 
mice and Ts65Dn-EE mice and between WT and Ts65Dn-EE mice (p < 0.001). The arrow indicates HFS; error bars, s.e.m.  
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5.1.3. Restoration of visual functions in Ts65Dn mice by environmental 
enrichment 
It has been recently reported that Ts65Dn mice exhibit a number of visual deficits similar to 
those reported in individuals with DS (Scott-McKean et al., 2010). Therefore, I moved to the 
visual system with the aim to investigate whether the beneficial effects exerted by EE are 
specific to the hippocampus or they are also detectable in the sensory cortices.  
          Using electrophysiological recordings of VEPs from V1, VA of WT (n = 6), Ts65Dn-
SC (n = 13) and Ts65Dn-EE (n = 5) mice was measured and, for the first time in this model, 
the OD properties of visual cortical neurons was analyzed by calculating the C/I VEP ratio as 
an index of V1 binocularity (Sale et al., 2007). VA of Ts65Dn-SC mice was lower (0.45 ± 
0.04c/deg) than that of WT controls (0.57 ± 0.02 c/deg) (Figure  4A). While it is well known 
that the C/I VEP ratio is in the 2.0–3.0 range in adult normal mice (Porciatti et al., 1999), 
reflecting the predominance of crossed fibres in retinal projections, I  found that the visual 
cortex of Ts65Dn-SC mice was not dominated by the contralateral eye, with a marked 
reduction in C/I VEP ratio compared to WT animals (C/I VEP ratio of Ts65Dn-SC: 1.26 ± 
0.18; C/I VEP ratio of WT mice: 2.36 ± 0.16) (Figure 4B). Moreover, I also report, in 
agreement with data from patients with DS, that Ts65Dn-SC mice did also display a robust 
increase in VEP latencies compared to WT controls in response to visual gratings of 0.05, 
0.1, 0.2, 0.3 and 0.4 spatial frequencies (WT 0.05: 125.99 ± 3.28 ms; 0.1: 130.56 ± 5.92 ms; 
0.2: 146.24 ± 9.26 ms; 0.3: 144.18 ± 8.85 ms; 0.4: 147.24 ± 8.72 ms; Ts65Dn-SC 0.05: 
132.79 ± 9.51 ms; 0.1: 145.33 ± 16.38 ms; 0.2: 152.42 ± 8.04 ms; 0.3: 161.03 ± 4.12 ms; 0.4: 
168.27 ± 12.89 ms) (Figure 4C). 
 EE completely reversed all visual function deficits displayed by Ts65Dn mice 
(Figure 4 A-C): the VA (0.59 ± 0.06) and the C/I VEP ratio (2.81 ± 0.27) of Ts65Dn-EE 
84 
 
mice, indeed, were not statistically different from those of WT mice; in addition, I found that 
VEP latencies in Ts65Dn-EE mice were significantly shorter than of Ts65Dn-SC mice, but 
did not differ from those recorded in WT controls (Ts65Dn-EE 0.05: 115.35 ± 16.50 ms; 0.1: 
126.33 ± 12.83 ms; 0.2: 132.25 ± 9.56 ms; 0.3: 132.93 ± 10.04 ms; 0.4: 137.30 ± 10.83 ms). 
Figure 4. Restoration of visual functions in Ts65Dn mice by environmental enrichment. Visual acuity (A),ocular 
dominance (B) and peak latency (C) assessed by electrophysiological recordings of VEPs from the primary visual cortex in 
WT (orange), Ts65Dn-SC (violet) and Ts65Dn-EE (yellow) mice. One Way ANOVA showed that a statistical difference in 
the mean values was present among the three groups for both visual acuity and C/I VEP ratio (p < 0.05 and p < 0.001, 
respectively); a multiple comparison procedure (Holm-Sidak method) showed a statistical difference between WT and 
Ts65Dn-SC mice and between Ts65Dn-nonEE mice and Ts65Dn-EE mice, but not between WT and Ts65Dn-EE mice (p = 
0.82 for visual acuity; p = 0.14 for C/I VEP ratio). VEP latencies of Ts65Dn-EE mice were statistically different from 
Ts65Dn-SC animals, but not from WT mice (Two Way RM ANOVA). *, statistical significance; error bars, s.e.m 
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5.1.4. Environmental enrichment  normalizes excessive  GABA  release in the 
hippocampus and  visual  cortex of  Ts65Dn mice  
Because substantial evidence suggests that excessive inhibition is critically involved in the 
cognitive deficits displayed by Ts65Dn mice (Siarey et al., 1997, Siarey et al., 1999, 
Kleschevnikov, 2004, Fernandez et al., 2007, Belichenko et al., 2009b), I investigated 
whether restoration of spatial learning abilities and DG long-term plasticity elicited by EE 
was accompanied by a reduced GABA release in the hippocampus. 
 Specifically, KCl-evoked release of [
3
H]GABA from synaptosomes in superfusion 
was measured in the hippocampus of WT (n = 16), Ts65Dn-SC (n = 7) and Ts65Dn-EE mice 
(n = 7) (Figure  5A). Moreover, since it was previously showed that EE is is able to reinstate 
plasticity in the visual cortex of adult animals through a reduction of GABAergic inhibition 
(Sale et al., 2007b, Baroncelli et al., 2010b), I also performed synaptosome analysis for 
GABA release in the primary visual cortex of the same animals (Figure 5B). I found that the 
stimulus-evoked release of GABA was markedly increased in both the hippocampus and the 
visual cortex of Ts65Dn-SC mice (hippocampus: 7.30 ± 0.85%; visual cortex: 10.63 ± 
0.850%) compared to WT animals (hippocampus: 4.71 ± 0.67%; visual cortex: 7.26 ± 
0.90%). In contrast, levels of depolarization-evoked overflow of GABA were markedly 
decreased in Ts65Dn-EE animals (hippocampus: 5.04 ± 1.02%; visual cortex: 7.22 ± 120%) 











Figure 5. Normalization of depolarization-evoked release of GABA from synaptosomes after exposure to 
environmental enrichment. 15 mM KCl evoked GABA release from hippocampal (A) and visual cortex (B) synaptosomes 
of WT (orange), Ts65Dn-SC (violet) and Ts65Dn-EE (yellow) mice.  Two Way ANOVA showed a significant difference 
among the different levels of group (p < 0.001); a multiple comparison procedure (Holm-Sidak method) showed that levels 
of GABA were significantly higher, for both the hippocampus and the visual cortex, in Ts65Dn-SC mice compared to WT 
animals, while no statistical difference was present between Ts65Dn-EE animals and WT mice (p = 0.79 for the 
hippocampus, p = 0.98 for the visual cortex). *, statistical significance;errorbars,s.e.m. 
 
5.1.5. Evaluation of fluoxetine pro-convulsive side effects in Ts65Dn mice 
Based on the potential to induce plastic responses in adult brain in a manner analogous to EE, 
fluoxetine has emerged as a putative pharmacological treatment for DS. Since previous 
studies in humans and animal models have reported that high doses of fluoxetine 
administration could have a pro-convulsive action  (Rosenstein et al., 1993, Oke et al., 2001, 
Zienowicz et al., 2005, Suchard, 2008, Heinen et al., 2012), I performed a preliminary 
analysis aimed at establishing a safe fluoxetine dose in my experimental model. I evaluated 
three decreasing drug concentrations within the range of fluoxetine dosing schemes generally  
used in laboratory rodents (see Methods for references), that is 40, 20 and 10 mg/kg/day, 
administered to both trisomic and WT mice. For the entire length of the treatment (8 weeks) I 
monitored, via behavioral observations, mouse survival and seizure susceptibility (Figure 6).  
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In WT mice, only one case of death (1 out of 7) was registered, when the maximum 
dose (WT-fluox40) was used, but no one case of seizures was ever observed. In trisomic 
mice, 4 out 10 of Ts65Dn-fluox40 mice and 1 out 7 of Ts65Dn-fluox20 died during the 8-
week observation period. There were no deaths among Ts65Dn-fluox10 mice (0 out of 8 
mice), water-treated Ts65Dn mice (0 out of 7 mice) and water-treated WT animals (0 out of 9 
mice) (Figure 6A).  
Tonic-clonic seizures were observed in a few animals (a total of 5 mice). All seizure 
episodes occurred in Ts65Dn-fluox40 and Ts65Dn-fluox20 mice (4 out of 10 and 1 out of 7, 
respectively) (Figure 6B).  
Taken together, these results indicate that a 10 mg/kg/day dose of fluoxetine did not 
result in any sudden death and was not associated with pro-convulsive side effects in the 
Ts65Dn background. Thus,  I used a 10 mg/kg/day dose to test the effects of fluoxetine on the 





































Figure 6. Assessment of severe side effects in fluoxetine treated Ts65Dn and WT mice. The percentage of unexpected 
and sudden death (A) and seizure (B) cases found in the four experimental groups of mice with three different dosing 
protocols of fluoxetine administered in the drinking water. In both analyses, no adverse cases were recorded for Ts65Dn-
fluox animals treated for 8 weeks with 10 mg/kg/day fluoxetine. 
  
5.1.6. Evaluation of spatial learning and memory after chronic administration 
of fluoxetine 
 I initially examined the effects of a pharmacological treatment with fluoxetine on the 
performance of Ts65Dn mice in MWM test. The analysis of swimming paths showed that the 
latency to find the hidden platform on the ninth day of training in non-treated WT mice (WT-
NT, 10.15 ± 3.04 sec; n = 5) was statistically shorter with respect to both non-treated Ts65Dn 
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(Ts65Dn-NT, 35.07 ± 5,88 s; n = 8) and treated Ts65Dn mice (Ts65Dn-FLX, 44 ± 5.86 s; n = 
8). While these data confirm a spatial learning deficit in adult trisomic mice, there was no 
statistical difference in the performance between treated and non-treated Ts65Dn mice. 
Performance of control  group of WT mice treated with  fluoxetine (WT-FLX, 23.55 ± 9.33 s; 
n = 4) did not statistically differ from that of non-treated WT mice (Figure 7). 
Figure 7. Effects of fluoxetine administration on spatial learning in Ts65Dn mice. (A) Learning curves for WT-NT 
(orange), Ts65Dn-NT (violet), Ts65Dn-FLX (yellow) and WT-FLX mice (green). (B) The histogram shows latency to locate 
the submerged platform on the last day of training for the four groups. Two Way RM ANOVA revealed a statistically 
significant interaction between the genotype group and the days of training (p < 0.05).  A Holm-Sidak multiple comparison 
procedure demonstrated a statistical difference at ninth training day between WT-NT and Ts65Dn-NT and between WT-NT 
and Ts65Dn-FLX (p < 0.05), but not between other experimental groups. *, statistical significance; error bars, s.e.m.    
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In line with data from literature, Ts65Dn mice demonstrated poor spatial memory in 
the probe trial. While WT-NT mice spent significantly longer time in the quadrant where the 
platform was placed during the period of training, Ts65Dn-NT mice showed no preference 
for the target quadrant, indicating that they did not remember the position of the hidden 
platform. On the other hand, Ts65Dn-FLX mice spent more time in the target of interest than 
in other quadrants (Figure 8). Even if this tendency was not statistically different from 
notreated Ts65Dn mice, it suggests a positive trend towards improvement of cognitive 
functions. 
Figure 8. Effects of fluoxetine administration on spatial memory in Ts65Dn mice. Probe trial for WT-NT (orange), 
Ts65Dn-NT (violet), Ts65Dn-FLX (yellow) and WT-FLX mice (green). Two Way RM ANOVA revealed a statistically 
significant difference between the four experimental groups for the factor of quadrant (p < 0.001).  A Holm-Sidak multiple 
comparison procedure revealed that while Ts65Dn-NT mice didn’t show any preference for the target quadrant (SO), WT 
mice spent significantly more time in the SO quadrant than in the other quadrants. Moreover, the time spent in the target 
quadrant was significantly longer in WT-NT mice than in the other three groups (p < 0.05), which instead did not 
statistically differ between each others. *, statistical significance; error bars, s.e.m.     
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5.1.7. Chronic treatment with fluoxetine improves short-term spatial memory 
impairment in Ts65Dn mice 
I also assessed short-term spatial memory abilities in the NPR task, which tests the animal 
ability to discriminate an old versus a novel position of a familiar object. An intact 
performance in the NPR relies on correct hippocampal functions (Mumby et al., 2002), and it 
has been recently reported that Ts65Dn mice display a robust deficit in this task 
(Kleschevnikov et al., 2012). 
During the acquisition phase, all experimental groups explored both objects equally, 
with a discrimination index close to the expected 50% (WT-NT, 54.87 ± 3.5%, n = 5; 
Ts65Dn-NT, 47.82 ± 4.45%, n = 4; Ts65Dn-FLX, 53.49 ± 1.62%, n = 8; WT-FLX, 55.22 ± 
3.26%, n = 4). In the test phase, while WT-NT mice spent more time exploring the moved 
object (discrimination index: 76.50 ± 3.48%), an impaired performance was found in 
Ts65Dn-NT mice, which spent even less time exploring the moved object with respect to the 
unmoved one, thus resulting in a low discrimination index (37.20 ± 7.58%). Fluoxetine 
appeared to fully rescue memory abilities in trisomic mice, which displayed a clear 
preference toward the moved object (discrimination index: 64.04 ± 5.65%). Treatment with 
fluoxetine did not significantly affect the outcome of euploid mice in the NPR test (64.52 ± 
7.41%) (Figure 9). 
Thus, chronic treatment with fluoxetine was able to rescue short-term spatial memory 








Figure 9. Spatial short-term memory improvement in Ts65Dn mice after chronic fluoxetine treatment.  Discrimination 
indexes for the acquisition and test phase of WT-NT (orange), Ts65Dn-NT (violet), Ts65Dn-FLX (yellow) and WT-FLX 
(green) mice. While there was no difference among the exploration indexes of the four experimental groups of mice during 
the acquisition phase (One way ANOVA, Holm-Sidak method, p = 0.377), a significantly lower exploration index was found 
in Ts65Dn-NT mice compared to WT-NT animals in the testing phase (One way ANOVA, Holm-Sidak method, p < 0.01). 
In contrast, Ts65Dn-FLX mice displayed an exploration index statistically higher than that of Ts-65Dn-NT animals, and not 
significantly different from that of WT-NT mice (One way ANOVA, Holm-Sidak method, p < 0.01; p = 0.112, respectively). 
Treatment with fluoxetine did not significantly affect the testing outcome of euploid mice (p = 0.188) .*, statistical 
significance; error bars, s.e.m. 
 
5.1.8.  Effects of chronic fluoxetine administration on hippocampal synaptic 
plasticity at the CA3-CA1 synapse 
The spatial memory impairment displayed by Ts65Dn mice has been repeatedly related to 
synaptic plasticity deficits in the hippocampus, thus I studied LTP in CA1 in response to TBS 
of the Schaffer collateral pathway, a form of long-term synaptic plasticity impaired in the 
Ts65Dn mouse brain (Siarey et al., 1997, Kleschevnikov, 2004, Costa and Grybko, 2005). 
 I found a significant potentiation of the response after TBS with respect to the 
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baseline level in both  WT-NT (167.91 ± 8.64%, n = 7 slices and 4 animals) and Ts65Dn-NT 
(134.68 ± 11.14%, n = 9 slices and 4 animals) mice. However, the level of potentiation was 
significantly lower in Ts65Dn-NT than in WT-NT mice, revealing a partial occlusion of 
synaptic plasticity in trisomic animals (Figure 10). A robust rescue of LTP was instead 
evident in Ts65Dn-FLX mice (167.31 ± 10.71%, n = 9 slices and 4 animals) (Figure 10). No 
significant change in LTP levels was found between WT-FLX (183.87 ± 12.40%, n = 8 slices 
and 5) and WT-NT animals. 
 
Figure 10. Recovery of LTP at Schaffer collateral – CA1 synapses in Ts65Dn mice treated with fluoxetine. Averaged 
data for LTP induced in WT-NT (orange), Ts65Dn-NT (violet), Ts65Dn-FLX (yellow) and WT-FLX (green) mice. While 
slices from all groups showed potentiation of the response after theta burst stimulation (TBS) (Two Way ANOVA, baseline 
vs. the last 20 min post-TBS, post-hoc Tukey test, p < 0.05), levels of LTP were significantly lower in Ts65Dn-NT than in 
WT-NT mice (Two Way ANOVA, baseline vs. the last 20 min post-TBS, pos-thoc Tukey test, p < 0.05). Conversely, LTP 
levels of Ts65Dn-FLX mice were significantly higher than those of Ts65Dn-NT animals, but did not differ from WT-NT 
animals (Two-Way ANOVA, pos-thoc Tukey test, p < 0.05 and p = 1.0, respectively). No significant changes were present 
between LTP levels of WT-NT and WT-FLX mice (p = 0.510). The arrow indicates TBS; error bars, s.e.m..     
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No significant changes were found in the I/O curves of the four experimental groups, 
indicating that Schaffer collaterals – CA1 synapse excitability was not affected by fluoxetine 
administration (Figure 11). 










Figure 11. Effects of chronic fluoxetine administration on Schaffer collaterals – CA1 synaptic excitability in Ts65Dn 
mice. Amplitude of f-EPSPs normalized to saturation level as a function of stimulation intensity in WT-NT (orange), 
Ts65Dn-NT (violet), Ts65Dn-FLX (yellow) and WT-FLX (green) mice. Two-way RM ANOVA revealed no changes among 
the different genotypes and treatments (p = 0.339). error bars, s.e.m..    
  
5.1.9. Chronic fluoxetine administration normalizes excessive  GABA  release 
in the hippocampus of Ts65Dn mice  
As discussed before, substantial evidence suggests that excessive inhibition is critically 
involved in the cognitive deficits displayed by Ts65Dn mice (Siarey et al., 1997, Siarey et al., 
1999, Kleschevnikov, 2004, Fernandez et al., 2007, Belichenko et al., 2009b). Thus, I 
investigated whether restoration of spatial memory abilities and long-term synaptic plasticity 
in the hippocampus elicited by fluoxetine was accompanied by a reduction of GABA release 
in the hippocampus. Specifically, KCl-evoked release of [
3
H]GABA from synaptosomes in 
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superfusion was measured in the hippocampus of WT-NT (n = 10), Ts65Dn-NT (n = 16), 
Ts65Dn-FLX (n = 12) and WT-FLX mice (n = 13) (Figure 12). 
I found that the stimulus-evoked release of GABA was increased in the hippocampus 
of Ts65Dn-NT mice (4.23 ± 0.21%) compared to WT-NT animals (3.11 ± 0.34%), thus 
confirming the previously established overinhibition effect. In contrast, the depolarization-
evoked overflow of GABA was decreased in Ts65Dn-FLX animals (3.48 ± 0.28%), which 
displayed GABA release levels very similar to those found in  WT-NT mice. Fluoxetine 












Figure 12. Fluoxetine normalizes GABA release in hippocampal synaptosomes of Ts65Dn mice. The graph reports 
quantification of 15 mM KCl evoked GABA release from hippocampal synaptosomes of WT-NT (orange), Ts65Dn-NT 
(violet), Ts65Dn-FLX (yellow) and WT-FLX (green) mice. One way ANOVA showed that GABA release in the four groups 
significantly differed among different experimental groups (p < 0.05). GABA levels were increased in the hippocampus of 
Ts65Dn-NT mice compared to WT-NT animals (multiple comparison procedure with Holm-Sidak method, p < 0.05). In 
contrast, GABA overflow was decreased in Ts65Dn-FLX animals, which displayed GABA levels very similar to those 
found in WT-NT mice and significantly lower than those of Ts65Dn-NT animals (multiple comparison procedure with 
Holm-Sidak method, p = 0.367 and p < 0.5, respectively). Fluoxetine treatment did not affect GABA release in WT-FLX 
mice. *, statistical significance; error bars, s.e.m. 
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5.2. Impact of environmental enrichment on visual system development in 
Ts65Dn mice 
In the second part of my Thesis I investigated whether exposure to EE from birth elicits 
beneficial effects on the developing visual system of Ts65Dn mice. I performed a quantitative 
study of maternal behaviour, a fundamental  mediator of the effects of EE during the earliest 
postnatal period (Sale et al., 2004), expressed by Ts65Dn females in different environmental 
conditions and found that enriched pups received higher levels of maternal care when 
compared with standard-reared pups. Moreover, my results suggest that pre-weaning onset of 
EE results in an acceleration of the visual system maturation in enriched Ts65Dn offspring. 
 
5.2.1. Maternal effects of environmental enrichment in Ts65Dn mice 
It has been demonstrated that maternal care exerts an essential role in the postnatal 
development of newborn rodents (Liu et al., 2000) and that an enhancement in the quantity 
and quality of maternal care induced by EE is able to accelerate the maturation of CNS (Sale 
et al., 2004). However, it is not known whether EE exerts the same positive effects on 
maternal behaviour in Ts65Dn females and whether this form of precocious EE may be used 
as a strategy to increase stimulation of trisomic offspring during early phases of life. Thus, I 
performed a detail observation of postpartum behaviour of Ts65Dn females reared in SC (n = 
6; n refers to a number of observed litters) and EE (n = 5) cages focusing on the presence of 
mother/helper female in the nest (passive stimulation), licking, stepping, nest building and 
arched-back nursing (Figure 13A-E). 
 
Mother/helper female in the nest (passive stimulation) 
 Tactile stimulation is an important factor of postnatal care received by the pups as it 
97 
 
regulates the expression of hormones important for development (Kuhn and Schanberg, 1998, 
Schanberg et al., 2003),  promotes recovery from perinatal cortical lesions, and affects adult 
pattern of cortical cell dendritic fields (Kolb and Gibb, 2010). The presence of mother in the 
nest during the early postnatal period and  physical contact with pups represents a passive 
form of tactile stimulation. In the present study, the time that Ts65Dn females spent in the 
nest in SC (72.45 ± 3.38%) was significantly lower respect to EE (91.66 ± 1.38%) (Figure 
13A), indicating that enriched pups experienced higher levels of passive stimulation. 
 
Stepping  
Active forms of maternal tactile stimulation are also critically involved in structural and 
functional processes of cerebral development in newborns (Weaver et al., 2004, Champagne 
and Curley, 2009). Evaluation of stepping, maternal behaviour resembling human massage, 
experienced by pups revealed the increased levels of these form of active maternal 
stimulation in EE respect to SC (EE: 48.77 ± 4.97%; SC: 19.92 ± 2.69%) (Figure 13B).  
 
Licking 
 Licking has been associated with hormonal regulation of growth and maturation of 
neuroendocrine function and behavioural responses to stress (Liu et al., 2000). Similarly to 
results reported for stepping, I found that pups raised in EE received higher levels of licking 
(62.89 ± 3.82%) than pups reared in SC (33.65 ± 2.15%) (Figure 13C), indicating that 
exposure to EE also favoured this form of active tactile stimulation of the offspring.  
 
Nest building  
For mice, the nest is an important factor in heat and humidity conservation, reproduction and 
protection from external stimuli. Therefore, the structure of the nest represents a notable 
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component of the quality of the maternal care. I found that enriched females spent more time 
in activities aimed at nest consolidation respect to females reared in SC (EE: 13.89 ± 2.44%; 
SC: 6.85 ± 1.28%) (Figure 13D).   
 
Arched-back nursing 
The amount of milk received by pups not only directly affects their early physical 
development, but may also have long-term effects by influencing adult weight and, in male 
mice, aggressiveness and their ability to become dominant adults (Latham and Mason, 2004). 
The availability of milk relies on nursing postures adopted by the mother, with an active form 
of nursing, such as the so-called arched-back nursing, providing better nourishment for the 
offspring than more passive forms, like supine and blanket nursing. Quantification of the time 
that Ts65Dn females spent in arched-back nursing demonstrated no difference between EE 
(45.22 ± 7.50%) and SC (45.55 ± 2.73%) (figure 13E), indicating that the offspring in both 















13. Environmental enrichment promotes postnatal care in Ts65Dn females. Cumulative frequencies of target behaviour 
recordings of Ts65Dn females during the first 11 postpartum days raised in SC (violet) and EE (yellow). T-test revealed a 
significant statistical difference between SC and EE  for the following behaviours: passive stimulation (p < 0.001) (A), 
stepping (p < 0.001) (B),  licking (p <0.001) (C) and nest building (p < 0.05) (D). There was not a difference between the 
two groups in the time spent in arched-back nursing (p = 0.965) (E). *, statistical significance; error bars, s.e.m. 
 
5.2.2. Acceleration of the timing of eye-opening in the offspring raised in 
environmental enrichment  
Eye opening is considered to be an important event in the maturation of visual system. Early 
visual experience influences the formation and strength of visual cortical synapses (Lu and 
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Constantine-Paton, 2004, Maffei et al., 2004, Wallace and Bear, 2004), the expression of 
immediate early gene (Tagawa et al., 2005) and the emergence of direction selectivity (Li et 
al., 2006) in the developing visual system. Therefore, I evaluated a timing of eye opening and 
found a significant delay in Ts65Dn offspring raised in SC (Ts65Dn-SC, 14.38 ± 0.3, n = 16) 
compared to WT littermates (WT-SC, 13.65 ± 0.17, n = 26); rearing in EE induced an 
acceleration of eye opening in both diploid and trisomic offspring, as illustrated by the 
precocious timing in WT (WT-EE, 12.68 ± 0.17, n = 22) and the compensation of the delay  















Figure 14. Accelerated timing of eye-opening in pups raised in environmental enrichment. Timing of eye opening in 
WT-SC (orange), Ts65Dn-SC (violet), Ts65Dn-EE (yellow) and WT-EE (green) offspring . One way ANOVA revealed a 
statistical difference between the four experimental groups (p < 0.001); a multiple comparison procedure (Holm-Sidak 
method) demonstrated a statistical difference between Ts65Dn-EE and Ts65Dn-SC, Ts65Dn-SC and WT-SC, and WT-SC 
and WT-EE  (p < 0.05), but not between WT-SC and Ts65Dn-EE, and  Ts65Dn-EE and WT-EE. *, statistical significance; 




5.2.3. Assessment of visual acuity development in Ts65Dn mice  
In line with recent data from literature (Scott-McKean et al., 2010), I confirmed that adult 
Ts65Dn mice display a deficit in VA similar to that observed among individuals with DS; 
importantly, this deficit was rescued after exposure to EE for six weeks. However, it is not 
known if this impairment of visual functions represents a consequence of disrupted 
neurodevelopmental mechanisms, or instead a sign of precocious neurodegenerative 
processes. 
 Therefore, I performed an electrophysiological assessment of VA maturation in 
Ts65Dn and WT offspring reared in both SC and EE at three different time points, P28, P35 
and P60. Analysis of electrophysiological recordings of VEPs from V1 revealed an 
impairment of VA at  P35 in Ts65Dn-SC mice respect to WT-SC (P28: WT-SC 0.43 ± 0.01 
c/deg, n = 5; Ts65Dn-SC 0.35 ± 0.03 c/deg, n = 5; P35: WT-SC 0.45 ± 0.02 c/deg, n = 8; 
Ts65Dn-SC 0.3 ± 0.03 c/deg, n = 6; P60: WT-SC 0.58 ± 0.02 c/deg, n = 13; Ts65Dn-SC 0.5 
± 0.03 c/deg, n = 5). VA of enriched trisomic offspring ( P28: Ts65Dn-EE 44 ± 0.03 c/deg, n 
= 9;P35: Ts65Dn-EE 0.44 ± 0.03 c/deg, n = 4; P60: Ts65Dn-EE 0.55 ± 0.13 c/deg, n = 6) did 
not differ from that of control WT-SC mice at any time point, indicating that EE from birth 
was able to normalize maturation of VA in Ts65Dn offspring. Euploid mice raised in EE did 
not differ as well from WT-SC mice at any time point (P28: WT-EE 0.53 ± 0.01, n = 6; P35: 











Figure 15. Environmental enrichment from birth prevents the delay in visual acuity maturation in Ts65Dn mice. 
Evaluation of VA by electrophysiological recordings of VEPs from V1 at P28, P35 and P60 in WT-SC (orange), Ts65Dn-SC 
(violet), Ts65Dn-EE (yellow) and WT-EE (green) mice. Two way ANOVA revealed a statistical difference between the four 
experimental groups (p < 0.001); a multiple comparison procedure (Tukey test) demonstrated an age-dependent statistical 








CHAPTER 6  
DISCUSSION 
6.1. Environmental enrichment and enviromimetics: amelioration of 
neurological phenotypes associated with Down syndrome in adulthood  
It has been believed for a long time that the consequences of developmental 
alterations in neurogenesis, cell migration and neuronal connectivity caused by T21 are 
irreversible in adulthood and that adult-onset treatment of neurological deficits associated 
with DS may bring a little benefit for the patients. Recent findings in Ts65Dn mice, a well 
established mouse model of DS, have suggested that it is possible to rescue DS-related 
cognitive dysfunction even in adulthood (Ehninger et al., 2008, Silva and Ehninger, 2009, 
Bartesaghi et al., 2011). I provide new evidence that two therapeutic strategies, EE and 
pharmacologic treatment with fluoxetine, may be successfully employed to reverse 
neurophysiological deficits in adult Ts65Dn mice.  
 
6. 1. 1. Effects of environmental enrichment on adult Ts65Dn mice 
My results show that EE can be successfully employed to favor recovery from cognitive 
impairment, synaptic plasticity failure, and visual deficits in adult Ts65Dn mice. Moreover, I 
also report that levels of GABA release are markedly increased in the hippocampus and in the 
visual cortex of Ts65Dn mice compared to WT animals, and that exposure to EE reduces the 
inhibitory transmission, bringing GABA release in the synaptosomes of trisomic mice back to 
WT control levels. Therefore, my findings show that EE may be particularly well suited to 
restore healthy levels of neural activity in brain disorders characterized by excessive levels of 
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inhibition, such as the DS. 
It has been demonstrated that a shift in the balance between excitatory and inhibitory 
neurotransmission to favor the latter compromises the ability of hippocampal circuits to 
undergo LTP (Kleschevnikov, 2004) and contributes to cognitive deficits in Ts65Dn mice 
(Fernandez and Garner, 2007, Fernandez et al., 2007). I found that six weeks of EE were 
sufficient to rescue both LTP in the DG in response to HFS of the perforant path and spatial 
memory abilities in the MWM test. This is the first evidence that EE in adult Ts65Dn mice 
can restore long-term synaptic plasticity in a neural circuit critically involved in spatial 
learning and memory. It has been previously reported that enriched Ts65Dn mice perform 
better in the MWM task than trisomic mice reared in standard conditions, but this 
improvement was female-specific (Martinez-Cue et al., 2002). In this previous study, Ts65Dn 
mice of both sexes were exposed to EE in the form of large social groups, 8-10 mice per 
cage. Considering that Ts65Dn male mice have a tendency toward social subordination 
(Martinez-Cue et al., 2006), it is possible that EE with this type of social configuration 
interfered with learning process in trisomic males. In agreement with this hypothesis, 
modifying the social component by exposing only two-three Ts65Dn littermates per cage to 
EE led to an improvement in spatial learning and memory in MWM also in males.  
The Ts65Dn model recapitulates not only the cognitive but also the sensory deficits of 
DS, offering an opportunity to evaluate the effectiveness of the same treatment on sensory 
functions. In the present work I focused on the visual system and found, in agreement with 
data published by Scott-McKean et al. (2010), a lower VA in Ts65Dn mice with respect to 
age-matched WT controls. Moreover, I also discovered, for the first time in this model, a 
robust increase in VEP latencies and an alteration of OD in the V1 expressed by the C/I VEP 
ratio. This OD alteration is reminiscent of the effects elicited by ambyopia (Holmes and 
Clarke, 2006), a condition frequently reported in people with DS (Tsiaras et al., 1999), 
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indicating that dysfunction of V1 may contribute to the poor vision in DS. This is in line with 
clinical data showing that the use of corrective lenses in people with DS does not eliminate 
major part of their visual deficits (John et al., 2004), suggesting that, in addition to 
anatomical eye abnormalities leading to refractive errors (Shapiro and France, 1985, 
Liyanage and Barnes, 2008), more subtle functional changes are present at the level of neural 
connections in the V1. I report a complete reversal of all visual deficits in Ts65Dn mice after 
adult-onset exposure to EE, providing the first evidence that, in addition to the hippocampus, 
the beneficial effects of EE are evident also in the visual system of trisomic mice.  
To investigate the cellular mechanisms of the observed functional improvements 
elicited by EE, I analyzed GABA release from hippocampal and visual cortex synaptosomes. 
I found increased levels of depolarization-evoked overflow of GABA in both the 
hippocampus and visual cortex of Ts65D mice respect to WT mice. Enhanced levels of 
inhibition in Ts65Dn mice was first documented in the hippocampus by use of 
electrophysiological techniques (Kleschevnikov, 2004). Subsequent studies provided also 
morphological evidence of an imbalance in excitation/inhibition ratio that favors the latter, by 
showing that immunoreactivity of several proteins associated with GABAergic synapses, 
such as GABAA receptor-associated protein (GABARAP), neuroligin 2, and vesicular GABA 
transporter, was increased in Ts65Dn mice (Belichenko et al., 2009b). These changes were 
accompanied by changes in the microcircuitry of inhibitory synaptic connections in the DG 
of Ts65Dn mice (Belichenko et al., 2004). Alterations of excitation/inhibition ratio are also 
present in the primary somatosensory cortex of Ts65Dn mice, where an increment of GAD67 
immunoreactivity was reported (Pérez-Cremades et al., 2010). My data provide new 
biochemical evidence of excessive GABAergic signaling in the hippocampus of Ts65Dn 
mice and demonstrate for the first time that an imbalance between inhibition and excitation is 
also evident in the V1 of trisomic mice, supporting the idea that excessive GABAergic 
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transmission is a general property of the Ts65Dn brain.  EE-induced lowering of GABAergic 
transmission in the hippocampus could directly contribute to the rescue of LTP in enriched 
Ts65Dn mice, as a pharmacological reduction of the inhibitory tone was found to reverse 
synaptic plasticity deficits in the DG of trisomic mice (Kleschevnikov, 2004, Fernandez et 
al., 2007).  
Together with a reduction in GABA signaling, other mechanisms could contribute to 
the EE-induced amelioration of cognitive and sensory deficits in Ts65Dn mice. Decreased 
neural stem cell proliferation rate and reduced neurogenesis during Ts65Dn forebrain 
development are thought to be among the key mechanisms at the basis of cognitive deficits in 
this mouse (Chakrabarti et al., 2007). Emerging evidence indicates that altered adult 
neurogenesis could also contribute to poor cognitive performance in Ts65Dn mice (Clark et 
al., 2006, Bianchi et al., 2010a, Bianchi et al., 2010b, Chakrabarti et al., 2011). EE paradigm 
has been shown to enhance adult hippocampal neurogenesis and learning ability in healthy 
rodents (Kempermann et al., 1998, Llorens-Martin et al., 2007) and recently the same effect 
of EE on postnatal neurogenesis has been reported in Ts65Dn mice (Chakrabarti et al., 2011). 
Therefore, I cannot rule out the possibility that the normalization of hippocampal function 
that I found in enriched Ts65Dn mice was facilitated by enhancement of adult neurogenesis.  
In adult rodents, EE is also able to enhance the synthesis and secretion of BDNF (Sale 
et al., 2007b, Sale et al., 2009, Spolidoro et al., 2009, Sale et al., 2010), a key regulator of 
neural circuit development and function (Park and Poo, 2013). The expression, secretion and 
actions of BDNF are directly influenced by neural activity, while secreted BDNF is capable 
of mediating many activity-dependent processes in the mammalian brain, including synapse 
plasticity and higher cognitive functions (Park and Poo, 2013). Ts65Dn mice have defective 
expression of BDNF in the hippocampus (Bianchi et al., 2010b, Fukuda et al., 2010) and the 
frontal cortex (Bimonte-Nelson et al., 2003) that could contribute to cognitive dysfunction in 
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this DS model. Thus, it is possible that EE in my study also restored BDNF levels, facilitating 
plastic brain mechanisms and promoting the reorganization of affected neural circuits in the 
mature Ts65Dn brain.  
EE also increases the expression of NGF in WT rodents (Torasdotter et al., 1998, 
Pham et al., 1999b, Ickes et al., 2000). NGF is a neurotrophic factor that enhances the 
survival, differentiation and function of specific neurons of the peripheral and central nervous 
system during development, adult life and aging  (Sofroniew et al., 2001). Moreover, it plays 
a role in the events of degeneration and repair of the nervous system in diseases with different 
etiologies, such as neurodegenerative disorders (Tirassa et al., 2002). In adult Ts65Dn mice, 
an abnormal retrograde transport of NGF has been associated with a progressive age-
dependent degeneration of BFCNs and a deterioration of learning and memory processes 
(Cooper et al., 2001, Hyde and Crnic, 2001, Hunter et al., 2003). Recently it has been shown 
that there is a deficit in the hippocampal NGF expression also in the early postnatal period 
(Bianchi et al., 2010b), that may contribute to a poor cognitive performance of young adult 
trisomic mice. Therefore, I could expect that the improvement of the hippocampal function 
and cognitive abilities that I found in young adult Ts65Dn mice after 6 weeks of EE was 
accompanied by the normalization of the NGF levels.   
It remains unclear to what extent every single component of EE contributes to its 
positive behavioral outcomes observed in this model of DS. A recently published paper has 
provided some insights into this area reporting that Ts65Dn females take advantage of 
sustained wheel running (Kida et al., 2013). However, in this study cognitive functions were 
improved only in mice that started physical activity early in life at weaning, while a cohort 





6. 1. 2. Effects of  fluoxetine treatment  on adult Ts65Dn mice 
In addition to EE, the antidepressant fluoxetine has been also shown to enhance neuronal 
plasticity in adult rodents. My findings show that fluoxetine can be safely and successfully 
employed to favor recovery from cognitive impairment and synaptic plasticity failure in adult 
Ts65Dn mice. Importantly, these beneficial effects were accompanied by normalization of 
GABA signaling, indicating that fluoxetine administration could be a good pharmacological 
alternative to cope with excessive levels of inhibition that are believed to be at the basis of 
DS associated neurological phenotypes (Fernandez and Garner, 2007). 
A recent study reported that a high-dose fluoxetine treatment did not rescue the 
behavioral impairments of Ts65Dn mice, but elicited severe side effects, including seizures 
and death (Heinen et al., 2012). Seizures are not among frequent side effects of fluoxetine 
administration in general clinical populations, but they could be observed in the case of 
fluoxetine intoxication (Prasher, 1993, Rosenstein et al., 1993, Oke et al., 2001, Suchard, 
2008). The fluoxetine dosing regimen followed by Heinen et al. (2012) corresponds to about 
80 mg/kg/day, i.e. a dose even two time higher than that at which I found a significant 
number of death and seizure cases. While this high-dosing scheme has proved safe and 
successful to promote neural plasticity in the rat (Maya Vetencourt et al., 2008), it could 
lower seizure threshold in Ts65Dn mice, that are more prone to develop epileptic attacks 
(Westmark et al., 2010).  
Before the onset of treatment, I reported a dose-response relationship of fluoxetine 
administration with respect to the adverse effects in Ts65Dn mice and found that death and 
convulsions could be completely avoided when the dosage was significantly decreased. 
Therefore, my data suggest that fluoxetine side effects are dose-dependent and provide 
evidence that assumption of ~10 mg/kg/day is an optimal dose to achieve a good benefit/risk 
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balance in Ts65Dn mice. In agreement with my data, it has been recently reported that the 
same low dose of fluoxetine increases neural plasticity in the mouse neural circuit involved in 
fear memory (Karpova et al., 2011). Since it has been previously reported that this protocol of 
chronic fluoxetine administration results in fluoxetine plasma levels within the therapeutic 
range in humans (Raju et al., 1999, Karpova et al., 2011), together these results encourage 
further studies aimed at investigating the applicability of fluoxetine to people with DS. 
I started the evaluation of fluoxetine treatment on adult Ts65Dn mice with the MWM 
test. My results confirmed a well established impairment of spatial learning and memory in 
non treated Ts65Dn mice. In line with data from the literature, this deficit was associated 
with abnormal LTP expression at the CA3-CA1 synapses. While there was no evident 
improvement in MWM performance in fluoxetine treated Ts65Dn animals, LTP expression 
was completely restored, indicating that fluoxetine treatment favoured synaptic plasticity in 
trisomic mice. Evidence exists that MWM performance can be impaired when LTP is 
preserved, and it has been also shown that a normal MWM performance may be possible 
even in animals in which LTP processes have been blocked (Cain et al., 1997, D'Hooge and 
De Deyn, 2001). It is important to note that the MWM is a challenging task for rodents, 
employing a variety of complex mnemonic processes. These processes encompass the 
acquisition and spatial localization of relevant visual cues that are subsequently processed, 
consolidated, retained, and then retrieved in order to successfully navigate and thereby locate 
a hidden platform to escape the water (Morris, 1984, McNamara and Skelton, 1993, Terry, 
2009).  
The hippocampus has been implicated as an essential structure for place learning in 
MWM, but other brain structures like basal forebrain, striatum, cerebellum and cerebral 
cortex were shown to be involved in MWM performance as well (D'Hooge and De Deyn, 
2001). Moreover, spatial learning in general and MWM performance in particular seem to be 
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dependent on the coordinate action of these different brain regions. Thus, dysfunction or 
disconnection of any brain structure that contribute to successful spatial navigation may 
compromise the ability of animals to complete the MWM task. Importantly, in DS and 
Ts65Dn mice almost all neural regions involved in spatial learning and memory are affected 
by trisomy. Altered neural development results in aberrant formation of hippocampus 
(Lorenzi and Reeves, 2006, Bianchi et al., 2010b) and cerebellum (Roper et al., 2006), which 
probably leads to poor MWM performance in young adult Ts65Dn mice, while precocious 
basal forebrain neuronal degeneration typically occurring in this model may accelerate age-
dependent decline of performance in this task. Additionally, clinical data from DS patients 
indicated altered prefrontal information processing (Rowe et al., 2006). It could be expected 
that a similar prefrontal dysfunction provoked by trisomy in Ts65Dn mice contribute to their 
poor MWM performance, as observed in rats with lesions of the prefrontal cortex that display 
impaired hidden-platform acquisition (Mogensen et al., 1995). Thus, my results suggest that 
the beneficial effects of fluoxetine on hippocampal function, here illustrated by rescue of LTP 
at CA3-CA1 synapses, are not powerful enough to compensate for all structural and 
functional deficits that may lead to ineffective spatial navigation and impaired MWM 
performance in this model of DS.  
On the other hand, I found that chronic fluoxetine treatment had beneficial effects on 
performance of Ts65Dn mice in a novel place recognition test, a hippocampus-based 
cognitive task less challenging than MWM. This cognitive paradigm evaluates the ability of 
mice to discriminate an old versus a novel position of the familiar object. While the role of 
the hippocampus in recognition memory is still controversial (Bussey et al., 2000, Clark et 
al., 2000, Clark et al., 2001, Mumby et al., 2002, Winters et al., 2004, Forwood et al., 2005, 
Good et al., 2007, Langston and Wood, 2010), the hippocampus appears to be critical under 
conditions in which recognition memory relies on spatial orientation during the task (Kesner 
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and Novak, 1982, Chiba et al., 1994, Bussey et al., 2000, Fortin et al., 2002). ). Since it has 
been demonstrated that dependence from the hippocampus in the novel place recognition test 
is particularly strong for short retention periods (Jessberger et al., 2009), I evaluated the 
effects of chronic fluoxetine treatment on short-term memory for place recognition in 
Ts65Dn mice. While I observed a total inability of Ts65Dn mice to distinguish an old versus 
a novel position of familiarized object, fluoxetine treated Ts65Dn mice performed as well as 
WT control group, demonstrating that 8 weeks of fluoxetine administration were sufficient to 
improve spatial orientation and to rescue the short-term recognition memory deficit of 
Ts65Dn mice in a task critically dependent on the hippocampal integrity.      
I also report that GABA release, markedly increased in the hippocampus of Ts65Dn 
mice compared to euploid animals, was brought back to normal WT control levels after 8 
weeks of chronic treatment with fluoxetine. Costa and Grybco (2005) showed that LTP 
deficits in CA3-CA1 hippocampal circuits can be rescued by bath application of picrotoxin, a 
noncompetitive antagonist for GABAA receptor chloride channels, indicating that increased 
GABAA-mediated inhibition in Ts65Dn mice may underlie the observed deficits. Thus, it is 
possible that fluoxetine-induced reduction of excessive GABAergic inhibition in the 
hippocampus of Ts65Dn mice enables normal excitatory/inhibitory ratio and abolishes LTP 
abnormalities at CA3-CA1 synapses. This is in line with the assumption that LTP 
mechanisms are actually intact in Ts65Dn mice, but that LTP is impaired by a shift in the 
excitation–inhibition ratio of the synaptic transmission evoked during electrical stimulation 
(Kleschevnikov, 2004, Costa and Grybko, 2005, Hanson et al., 2007).  
Fluoxetine might elicit a reduction of GABA release by increasing brain 5-HT levels. 
Consistent with this hypothesis, it has been reported that 5-HT inhibits GABA release in 
interneuron subtypes of several brain regions via a presynaptic mechanism mediated by 5-
HT1/2 receptor families (Koyama et al., 1999, Xiang and Prince, 2003), probably regulating 
112 
 
the availability of transmitter vesicles (Wang and Zucker, 1998). These results are in good 
agreement with data obtained from adult rats exposed to either EE conditions or to fluoxetine 
administration. In both models, it has been shown that an increase in 5-HT levels is 
accompanied by a reduced brain GABA extracellular release (Sale et al., 2007b, Maya 
Vetencourt et al., 2008, Baroncelli et al., 2010b). 
Even if I focused on GABA release, I cannot exclude the possibility that fluoxetine 
might improve memory abilities and synaptic plasticity in Ts65Dn mice also via other 
mechanisms. Similarly to EE, chronic fluoxetine treatment increases the expression of the 
neurotrophin BDNF in limbic structures, most notably in the hippocampus (Nibuya et al., 
1995, D'Sa and Duman, 2002). It is important to note that BDNF plays an important role in 
synaptic plasticity as it activates distinct mechanisms to regulate the induction, early 
maintenance, and late maintenance phases of LTP (Bramham and Messaoudi, 2005). For 
example, genetic deletion of BDNF in mice disrupted normal induction of LTP in the CA1 
region of the hippocampus (Korte et al., 1995, Xie et al., 2000), and this defect was rescued 
by reintroducing BDNF (Korte et al., 1996, Patterson et al., 1996). Moreover, chelation of 
endogenously secreted BDNF with TrkB–IgG or using antibodies against BDNF reduces 
LTP (Figurov et al., 1996, Kang et al., 1997). As mentioned in the previous chapter, Ts65Dn 
mice have defective expression of BDNF in the hippocampus (Bianchi et al., 2010b, Fukuda 
et al., 2010). Bianchi et al. (2010) showed that, in young Ts65Dn mice, this deficit could be 
successfully treated by fluoxetine administration, bringing back BDNF to normal WT control 
levels. Therefore, it is likely that fluoxetine results in a similar upregulation of BDNF 





6.2. Developmental impact of environmental enrichment in Ts65Dn mice  
Studies in mouse models of DS have enabled a better understanding of aberrant molecular 
and cellular mechanisms underlying deficits in the mature and aging nervous system. 
However, it is still unclear to what extent developmental alterations induced by trisomy 
contribute to these deficits observed in adulthood. In order to address this question, I focused 
on the developing visual system in Ts65Dn mice. Understanding this system is of particular 
relevance to individuals with DS who, in addition to having ocular abnormalities including 
strabismus, astigmatism, anisometropia and inaccurate accommodation (da Cunha and 
Moreira, 1996, Wong and Ho, 1997, Woodhouse et al., 1997, Cregg et al., 2001, Haugen and 
Hovding, 2001), have also lower VA and contrast sensitivity (John et al., 2004, Suttle and 
Turner, 2004). Moreover, the maturation of visual system is a good model to evaluate the 
impact of enhanced environmental stimulation on central nervous system development. It has 
been shown in normally developing mice that rearing from birth in EE induces functional and 
anatomical changes leading to an acceleration of visual system development that is evident at 
the behavioral, electrophysiological and molecular level (Cancedda et al., 2004, Sale et al., 
2004, Landi et al., 2007a). My findings provide initial evidence that increased multisensory 
stimulation provided by pre-weaning EE could be employed as a therapeutic strategy to 
counteract aberrant development of CNS in Ts65Dn mice.  
 
6.2.1. Maternal effects of environmental enrichment in Ts65Dn mice 
Maternal care is one of the most important sources of sensory experience during the early 
postnatal period (Hofer, 1984, Ronca et al., 1993, Liu et al., 2000) and it plays an important 
role in the regulation of nervous system development, with long-term consequences on brain 
functioning in adulthood  (Fleming et al., 1997, Meaney and Szyf, 2005, Champagne et al., 
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2008). Here I provide the first evidence that EE is able to enhance maternal care in Ts65Dn 
mothers,  leading to increased sensory stimulation of trisomic pups during this early phase of 
development. 
Ts65Dn females have been characterized as poor mothers since they express low 
levels of maternal care, frequently abandoning their litters (Moore et al., 2010). In the rodent 
maternal care model, naturally-occurring variations in the amount of maternal licking and 
grooming during the first days of life have been associated with individual differences in 
cognitive functioning, emotionality and stress resilience in adult offspring (Liu et al., 1997, 
Liu et al., 2000, Bredy et al., 2003, Weaver et al., 2005). Pups that experience a high level of 
maternal care exhibit greater spatial learning and memory performances in adulthood (Liu et 
al., 2000, Bredy et al., 2003), and reduced anxiety and stress responsiveness (Liu et al., 
1997). On the other hand, the offspring of mothers who exhibit reduced maternal care are 
more susceptible to stress-related disease (Liu et al., 1997), enter puberty earlier and show 
altered sexual behavior (Cameron et al., 2008). Therefore, it could be hypothesized that poor 
maternal care displayed by Ts65Dn females could additionally compromise DS associated 
phenotypes in pups carrying trisomy.  
Rearing in EE was able to optimize levels of maternal stimulation received by pups, 
resulting in higher levels of maternal care expressed by enriched Ts65Dn females compared 
to standard-reared animals. I found increased levels of licking and stepping received by 
enriched pups during the first eleven postnatal days. The enhancement of these two active 
forms of sensory stimulation was associated with an increased presence of the mother or 
other females in the nest, resulting in a strong tactile stimulation in enriched conditions. 
Compared to standard-reared trisomic mothers, enriched Ts65Dn females also spent more 
time in activities aimed at nest building and nest consolidation, which can lead to a more 
protective ambient for the growth and development of the offspring. Interestingly, I observed 
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no difference in the time spent in arched-back nursing between EE and SC, indicating that the 
offspring in both experimental conditions received similar amounts of milk.  
My findings support the hypothesis that increased maternal care is a key mediator of 
the effects of EE on developing pups (Sale et al., 2004). Living in an EE setting provides 
intense maternal touch as an alternative source of environmental stimulation during the first 
days of rodent life, the period characterized with a lack of direct interaction with the 
surroundings. The effects of EE on the offspring development were reproduced in standard-
reared rat pups that were exposed to a daily massage, a procedure that mimics active forms of 
maternal tactile stimulation, during their first ten postnatal days of life (Guzzetta et al., 2009). 
Importantly, it has been previously shown that this protocol is able to compensate for the 
deleterious effects of long-lasting maternal deprivation (Schanberg and Field, 1987, Burton et 
al., 2007, Chatterjee et al., 2007).  
It would be important to evaluate in coming studies the extent to which different 
environmental conditions affect the physiology of pregnant Ts65Dn females. Placental 
exchanges from the mother to the fetus provide the offspring with respiratory gases, nutrients 
and hormones necessary for intrauterine fetal growth and development (Anthony et al., 
1995). It is expected that any modification of maternal physiology induced by environmental 
factors would alter the capacity of placenta to deliver supplies to fetus. Indeed, in both 
humans and rodents, exposure of pregnant females to stress induces unfavourable 
physiological response to pregnancy, leading to physical and mental health problems in the 
offspring that could be manifested at different stages of life (Beydoun and Saftlas, 2008). On 
the other hand, it has been shown that exposure of female rats to EE for the entire length of 
gestation is able to modulate dynamics of IGF-1 (Sale et al., 2007a). IGF-1 is a circulating 
polypeptide structurally related to insulin that mediates many of the effects of growth 
hormone (GH) in the body (Jones and Clemmons, 1995) and plays also an important role in 
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the developing brain (Anlar et al., 1999). Sale et al. (2007a) proposed an interesting model in 
which sustained physical exercise during pregnancy increases IGF-I in the mother, promoting 
placental transfer of nutrients to the fetus; this would in turn lead to increased amounts of 
IGF-I autonomously produced by the fetus, resulting in the accelerated development of 
nervous system. Therefore, it is possible that exposing Ts65Dn females to EE during 
pregnancy may influence the development of trisomic fetuses in a similar manner. 
 
6.2.2. Influence of pre-weaning onset of environmental enrichment on visual 
system development in Ts65Dn mice  
It has been shown that EE exerts positive effects on experience-dependent plasticity 
processes involved in neural wiring and refinement of the visual cortex during critical periods 
in normally developing pups (Cancedda et al., 2004, Landi et al., 2007a). Here I report that 
pre-weaning EE is able to influence neural development also under pathological conditions,  
promoting visual system maturation in enriched Ts65Dn offspring. 
In normally developing mice, eye opening occurs around P10 – P13 (Smith and 
Trachtenberg, 2007). In my study diploid control mice reared in SC opened their eyes within 
this expected time window, while their trisomic littermates displayed a delay in eye opening. 
Given that the timing of eye opening corresponds closely to that of the development of other 
epidermal structures in the body (Maconnachie, 1979, Findlater et al., 1993), its delay in 
Ts65Dn pups is an indicator of the more general retardation in their physical growth and 
maturation. This deficit is in line with previously reported delays in the achievement of 
certain physical and sensorimotor milestones observed in both Ts65Dn pups (Holtzman et al., 
1996) and infants and children with DS (Hayes and Batshaw, 1993). It is important to note 
that before eye-opening neuronal activities within the visual cortex are generated mainly 
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intrinsically, while after it sensory inputs from eyes reach the visual cortex and modulate the 
pattern of network activity (Rochefort et al., 2009) . Therefore, a delay in eye opening can 
negatively influence the maturation of the visual cortex.  
The progressive increase of VA is a sensitive parameter of visual system maturation. 
For the first time in literature my data suggest that this process is altered in Ts65Dn pups. 
While WT mice reared in SC showed linear progression of VA with time, this was not the 
case in standard-reared Ts65Dn offspring, which even displayed a drop of function at P35. 
Importantly, at P60 Ts65Dn mice reached adult-like VA value typical of WT controls. 
Therefore, despite a non linear maturation of VA,  it seems that the visual system of trisomic 
mice is able to compensate this deficit at the end of developmental period. In agreement with 
findings reported by Scott-McKean et al. (2010), my data obtained from adult Ts65Dn mice 
demonstrate that VA impairment emerges again later in life, at about 4 months of age. 
Although these findings may appear discrepant at first sight, they actually suggest the 
possibility that the VA deficit observed in older adult animals could be rather a sign of 
precocious neurodegenerative processes than the direct outcome of aberrant neural 
development.  
I demonstrated that rearing in EE promotes visual system maturation in both Ts65Dn 
and WT mice. EE from birth was able to compensate the delay of eye opening in Ts65Dn 
offspring. Moreover, VA of enriched trisomic mice was comparable with that of standard-
reared WT littermates at all investigated developmental stages. In line with data form 
literature (Cancedda et al., 2004, Sale et al., 2004), in my study enrichment exerted  profound 
effects on WT animals as well, leading to a precocious eye opening and anticipated 
maturation of VA. 
Molecular and cellular mechanisms at the basis of the positive effects of EE on visual 
system development in Ts65Dn mice remain to be elucidated. Some of the mechanisms 
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underlying the accelerated maturation of visual system in enriched euploid animals 
(Cancedda et al., 2004, Sale et al., 2004) could be activated as well by EE during early 
developmental phase in trisomic mice. One of the key molecules involved in the control of 
visual cortical development during a critical period early in life is the neurotrophin BDNF 
(Berardi et al., 2003). Reduction of BDNF levels have been already reported in the 
hippocampus of Ts65Dn mice at P15 (Bianchi et al., 2010b), thus it is possible that a similar 
deficit exist also in the visual cortex. Given that acceleration of visual system development in 
WT mice is accompanied by increased levels of BDNF (Cancedda et al., 2004, Sale et al., 
2004), a similar BDNF response to EE could be expected also in Ts65Dn mice. Interestingly, 
the enrichment-induced enhancement of BDNF in WT animals is evident already at P7, i.e. 
even before eye opening (Cancedda et al., 2004, Sale et al., 2004), supporting the hypothesis 
that different levels of maternal care in enriched condition could induce the acceleration of 
eye opening in Ts65Dn mice.  
Another molecule that has a key role in visual development and responds to EE 
paradigm is IGF-I.  It has been shown that IGF-I expression is increased at P18 in the visual 
cortex of rats raised in EE compared to standard-reared animals. Moreover, exogenous IGF-I 
supply mimics, whereas blocking IGF-I action prevents, the effects of EE on VA maturation 
(Ciucci et al., 2007). Importantly, initial clinical evidence exists that IGF-1 could also be 
involved in the effects of early EE on human brain. Guzzetta et al. (2009) reported that 
accelerated VA maturation in healthy pre-term infants exposed to massage therapy, a form of 
early EE, was associated with increased levels of plasma IGF-1. So far, the role of IGF-1 in 
the pathophysiology of DS has been studied only in the context of growth retardation. 
Growth retardation is a typical feature of DS and it becomes evident in infants from the age 
of 6 months, when GH starts to regulate growth (Anneren et al., 1990). While serum levels of 
GH in DS children were normal, serum IGF-1 levels did not rise during childhood, as occurs 
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in normally developing children, and remained at a low level throughout life (Anneren et al., 
1990). Considering the relevance of IGF-1 for CNS development (Anlar et al., 1999) and the 
wide spectrum of its effects on the adult brain (Torres-Aleman, 1999), it would be important 
to investigate whether and to what extent this deficit in circulating levels of IGF-1 influence 
DS neural phenotypes during different stages of life. 
 
6.3. Conclusions 
Major findings from animal models suggest that a number of behavioral, cognitive and 
neurological symptoms associated with neurodevelopmental and neurodegenerative disorders 
may be ameliorated or reduced with exposure to enriched environments, likely via 
mechanisms of experience dependent neural plasticity  
One may argue that today individuals with DS are already highly stimulated. Indeed,  
in developed countries children with DS almost always undergo a sensory integration therapy 
that, conceptualized as an active process in which the child engages with the physical 
environment to promote neurological change, shares several key principles of EE (Reynolds 
et al., 2010). However, in the past few decades improved medical assistance caused a marked 
prolongation of life expectancy in people with DS, who now may also outlive their parents, 
leading to an emerging risk of social and cognitive impoverishment of this population in 
older age. Moreover, there is a high prevalence of depression in young adult DS individuals 
that may lead to additional decline in adaptive behavior and cognitive performance during 
mid and late adulthood (Burt et al., 1992). Therefore, intervention paradigms based on 
exposure of adult subjects to novel stimuli and learning experiences alone, or in a 
combination with antidepressants such as fluoxetine, may be well suited to prevent additional 
cognitive deterioration in aging individuals with DS.  
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On the other hand, the early intervention programs of newborns with DS could also 
benefit from translational research. In parallel to the effects obtained in massaged rats, it has 
been reported that enriching the environment in terms of body massage during the first 
months of life accelerates development of some brain functions, such as faster reduction in 
the latency of VEPs and an increase in behavioral visual acuity, in healthy pre-term infants 
(Guzzetta et al., 2009). An ongoing clinical study undertaken by our collaborators at the 
Stella Maris Scientific Institute (Calambrone, Pisa, Italy) evaluates the effects of a similar 
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